Document:

Exhibit 10.3

                                ESCROW AGREEMENT

      THIS ESCROW AGREEMENT (this "Agreement") is made and entered into as of
February 24, 2004 by RELIV' INTERNATIONAL INC., an Delaware corporation (the
"Company"); CORNELL CAPITAL PARTNERS, LP, a Delaware limited partnership (the
"Investor"); and BUTLER GONZALEZ LLP (the "Escrow Agent").

                                   BACKGROUND

      WHEREAS, the Company and the Investor have entered into an Standby Equity
Distribution Agreement (the "Standby Equity Distribution Agreement") dated as of
the date hereof, pursuant to which the Investor will purchase the Company's
Common Stock, par value $.0001 per share (the "Common Stock"), at a price per
share equal to the Purchase Price, as that term is defined in the Standby Equity
Distribution Agreement, for an aggregate price of up to Five Million Dollars
($5,000,000). The Standby Equity Distribution Agreement provides that on each
Advance Date the Investor, as that term is defined in the Standby Equity
Distribution Agreement, shall deposit the Advance pursuant to the Advance Notice
in a segregated escrow account to be held by Escrow Agent and the Company shall
deposit shares of the Company's Common Stock, which shall be purchased by the
Investor as set forth in the Standby Equity Distribution Agreement, with the
Escrow Agent, in order to effectuate a disbursement to the Company of the
Advance by the Escrow Agent and a disbursement to the Investor of the shares of
the Company's Common Stock by Escrow Agent at a closing to be held as set forth
in the Standby Equity Distribution Agreement (the "Closing").

      WHEREAS, Escrow Agent has agreed to accept, hold, and disburse the funds
and the shares of the Company's Common Stock deposited with it in accordance
with the terms of this Agreement.

      WHEREAS, in order to establish the escrow of funds and shares to effect
the provisions of the Standby Equity Distribution Agreement, the parties hereto
have entered into this Agreement.

      NOW THEREFORE, in consideration of the foregoing, it is hereby agreed as
follows:

      1. Definitions. The following terms shall have the following meanings when
used herein:

            a. "Escrow Funds" shall mean the Advance funds deposited with the
Escrow Agent pursuant to this Agreement.

            b. "Joint Written Direction" shall mean a written direction executed
by the Investor and the Company directing Escrow Agent to disburse all or a
portion of the Escrow Funds or to take or refrain from taking any action
pursuant to this Agreement.

            c. "Common Stock Joint Written Direction" shall mean a written
direction executed by the Investor and the Company directing Investor's Counsel
to disburse all

<PAGE>

or a portion of the shares of the Company's Common Stock or to refrain from
taking any action pursuant to this Agreement.

      2. Appointment of and Acceptance by Escrow Agent.

            a. The Investor and the Company hereby appoint Escrow Agent to serve
as Escrow Agent hereunder. Escrow Agent hereby accepts such appointment and,
upon receipt by wire transfer of the Escrow Funds in accordance with Section 3
below, agrees to hold, invest and disburse the Escrow Funds in accordance with
this Agreement.

            b. The Investor and the Company hereby appoint the Escrow Agent to
serve as the holder of the shares of the Company's Common Stock which shall be
purchased by the Investor. The Escrow Agent hereby accepts such appointment and,
upon receipt via D.W.A.C or the certificates representing of the shares of the
Company's Common Stock in accordance with Section 3 below, agrees to hold and
disburse the shares of the Company's Common Stock in accordance with this
Agreement.

            c. The Company hereby acknowledges that the Escrow Agent is counsel
to the Investor in connection with the transactions contemplated and referenced
herein. The Company agrees that in the event of any dispute arising in
connection with this Escrow Agreement or otherwise in connection with any
transaction or agreement contemplated and referenced herein, the Escrow Agent
shall be permitted to continue to represent the Investor and the Company will
not seek to disqualify such counsel.

      3. Creation of Escrow Account/Common Stock Account.

            a. On or prior to the date of this Agreement the Escrow Agent shall
establish an escrow account for the deposit of the Escrow Funds entitled as
follows: Reliv' International Inc/Cornell Capital Partners, LP. The Investor
will wire funds to the account of the Escrow Agent as follows:

Bank:                                     Wachovia, N.A. of New Jersey

Routing #:                                031201467

Account #:                                2020000659170

Name on Account:                          Butler Gonzalez LLP as Escrow Agent

Name on Sub-Account:                      Reliv' International Inc/Cornell
                                          Capital Partners, LP Escrow account

            b. On or prior to the date of this Agreement the Escrow Agent shall
establish an account for the D.W.A.C. of the shares of Common Stock. The Company
will D.W.A.C. shares of the Company's Common Stock to the account of the Escrow
Agent as follows:

Brokerage Firm:                           Crown Financial

Clearing House:                           Fiserv

                                       2
<PAGE>

Account #:                                56797702
DTC #:                                    0632
Name on Account:                          Butler Gonzalez LLP Escrow Account

      4. Deposits into the Escrow Account. The Investor agrees that it shall
promptly deliver all monies for the payment of the Common Stock to the Escrow
Agent for deposit in the Escrow Account at the time provided for such payment in
the Standby Equity Distribution Agreement.

      5. Disbursements from the Escrow Account.

            a. At such time as Escrow Agent has collected and deposited
instruments of payment in the total amount of the Advance and has received such
Common Stock via D.W.A.C from the Company which are to be issued to the Investor
pursuant to the Standby Equity Distribution Agreement, the Escrow Agent shall
notify the Company and the Investor. The Escrow Agent will continue to hold such
funds until the Investor and Company execute and deliver a Joint Written
Direction directing the Escrow Agent to disburse the Escrow Funds pursuant to
Joint Written Direction at which time the Escrow Agent shall wire the Escrow
Funds to the Company. Immediately upon the date that the Investor shall have an
obligation to pay an Advance to the Company and the Company shall have an
obligation to issue to the Investor shares of the Company's Common Stock
pursuant to the Standby Equity Distribution Agreement, the Investor and the
Company shall be obligated to, and shall execute and deliver to the Escrow Agent
a Joint Written Directions directing the Escrow Agent to disburse the Escrow
Funds to the Company and the shares of Common Stock to the Investor. Failure of
either party to execute the Joint Written Disbursements at the time an Advance
is due shall constitute a material breach of the Standby Equity Distribution
Agreement and this Agreement. In disbursing such funds, Escrow Agent is
authorized to rely upon such Joint Written Direction from Company and may accept
any signatory from the Company listed on the signature page to this Agreement
and any signature from the Investor that Escrow Agent already has on file.
Simultaneous with delivery of the executed Joint Written Direction to the Escrow
Agent the Investor and Company shall execute and deliver a Common Stock Joint
Written Direction to the Escrow Agent directing the Escrow Agent to release via
D.W.A.C to the Investor the shares of the Company's Common Stock. In releasing
such shares of Common Stock the Escrow Agent is authorized to rely upon such
Common Stock Joint Written Direction from Company and may accept any signatory
from the Company listed on the signature page to this Agreement and any
signature from the Escrow Agent has on file.

      In the event the Escrow Agent does not receive the amount of the Advance
from the Investor or the shares of Common Stock to be purchased by the Investor
from the Company, the Escrow Agent shall notify the Company and the Investor.

      In the event that the Escrow Agent has not received the Common Stock to be
purchased by the Investor from the Company, in no event will the Escrow Funds be
released to the Company until such shares are received by the Escrow Agreement.
For purposes of this Agreement, the term "Common Stock certificates" shall mean
Common Stock certificates to be purchased pursuant to the respective Advance
Notice pursuant to the Standby Equity Distribution Agreement.

                                       3
<PAGE>

      6. Deposit of Funds. The Escrow Agent is hereby authorized to deposit the
wire transfer proceeds in the Escrow Account.

      7. Suspension of Performance: Disbursement Into Court.

            a. Escrow Agent. If at any time, there shall exist any dispute
between the Company and the Investor with respect to holding or disposition of
any portion of the Escrow Funds or the Common Stock or any other obligations of
Escrow Agent hereunder, or if at any time Escrow Agent is unable to determine,
to Escrow Agent's sole satisfaction, the proper disposition of any portion of
the Escrow Funds or Escrow Agent's proper actions with respect to its
obligations hereunder, or if the parties have not within thirty (30) days of the
furnishing by Escrow Agent of a notice of resignation pursuant to Section 9
hereof, appointed a successor Escrow Agent to act hereunder, then Escrow Agent
may, in its sole discretion, take either or both of the following actions:

                  i. Suspend the performance of any of its obligations
(including without limitation any disbursement obligations) under this Escrow
Agreement until such dispute or uncertainty shall be resolved to the sole
satisfaction of Escrow Agent or until a successor Escrow Agent shall be
appointed (as the case may be); provided however, Escrow Agent shall continue to
invest the Escrow Funds in accordance with Section 8 hereof; and/or

                  ii. petition (by means of an interpleader action or any other
appropriate method) any court of competent jurisdiction in any venue convenient
to Escrow Agent, for instructions with respect to such dispute or uncertainty,
and to the extent required by law, pay into such court, for holding and
disposition in accordance with the instructions of such court, all funds held by
it in the Escrow Funds, after deduction and payment to Escrow Agent of all fees
and expenses (including court costs and attorneys' fees) payable to, incurred
by, or expected to be incurred by Escrow Agent in connection with performance of
its duties and the exercise of its rights hereunder.

                  iii. Escrow Agent shall have no liability to the Company, the
Investor, or any person with respect to any such suspension of performance or
disbursement into court, specifically including any liability or claimed
liability that may arise, or be alleged to have arisen, out of or as a result of
any delay in the disbursement of funds held in the Escrow Funds or any delay in
with respect to any other action required or requested of Escrow Agent.

      8. Investment of Escrow Funds. The Escrow Agent shall deposit the Escrow
Funds in a non-interest bearing money market account.

      If Escrow Agent has not received a Joint Written Direction at any time
that an investment decision must be made, Escrow Agent may retain the Escrow
Fund, or such portion thereof, as to which no Joint Written Direction has been
received, in a non-interest bearing money market account.

      9. Resignation and Removal of Escrow Agent. Escrow Agent may resign from
the performance of its duties hereunder at any time by giving thirty (30) days'
prior written notice to the parties or may be removed, with or without cause, by
the parties, acting jointly, by furnishing a Joint Written Direction to Escrow
Agent, at any time by the giving of ten (10) days'

                                       4
<PAGE>

prior written notice to Escrow Agent as provided herein below. Upon any such
notice of resignation or removal, the representatives of the Investor and the
Company identified in Sections 13a.(iv) and 13b.(iv), below, jointly shall
appoint a successor Escrow Agent hereunder, which shall be a commercial bank,
trust company or other financial institution with a combined capital and surplus
in excess of $10,000,000.00. Upon the acceptance in writing of any appointment
of Escrow Agent hereunder by a successor Escrow Agent, such successor Escrow
Agent shall thereupon succeed to and become vested with all the rights, powers,
privileges and duties of the retiring Escrow Agent, and the retiring Escrow
Agent shall be discharged from its duties and obligations under this Escrow
Agreement, but shall not be discharged from any liability for actions taken as
Escrow Agent hereunder prior to such succession. After any retiring Escrow
Agent's resignation or removal, the provisions of this Escrow Agreement shall
inure to its benefit as to any actions taken or omitted to be taken by it while
it was Escrow Agent under this Escrow Agreement. The retiring Escrow Agent shall
transmit all records pertaining to the Escrow Funds and shall pay all funds held
by it in the Escrow Funds to the successor Escrow Agent, after making copies of
such records as the retiring Escrow Agent deems advisable and after deduction
and payment to the retiring Escrow Agent of all fees and expenses (including
court costs and attorneys' fees) payable to, incurred by, or expected to be
incurred by the retiring Escrow Agent in connection with the performance of its
duties and the exercise of its rights hereunder.

      10. Liability of Escrow Agent.

            a. Escrow Agent shall have no liability or obligation with respect
to the Escrow Funds except for Escrow Agent's willful misconduct or gross
negligence. Escrow Agent's sole responsibility shall be for the safekeeping,
investment, and disbursement of the Escrow Funds in accordance with the terms of
this Agreement. Escrow Agent shall have no implied duties or obligations and
shall not be charged with knowledge or notice or any fact or circumstance not
specifically set forth herein. Escrow Agent may rely upon any instrument, not
only as to its due execution, validity and effectiveness, but also as to the
truth and accuracy of any information contained therein, which Escrow Agent
shall in good faith believe to be genuine, to have been signed or presented by
the person or parties purporting to sign the same and conform to the provisions
of this Agreement. In no event shall Escrow Agent be liable for incidental,
indirect, special, and consequential or punitive damages. Escrow Agent shall not
be obligated to take any legal action or commence any proceeding in connection
with the Escrow Funds, any account in which Escrow Funds are deposited, this
Agreement or the Standby Equity Distribution Agreement, or to appear in,
prosecute or defend any such legal action or proceeding. Escrow Agent may
consult legal counsel selected by it in the event of any dispute or question as
to construction of any of the provisions hereof or of any other agreement or its
duties hereunder, or relating to any dispute involving any party hereto, and
shall incur no liability and shall be fully indemnified from any liability
whatsoever in acting in accordance with the opinion or instructions of such
counsel. The Company and the Investor jointly and severally shall promptly pay,
upon demand, the reasonable fees and expenses of any such counsel and Escrow
Agent is hereby authorized to pay such fees and expenses from funds held in
escrow.

            b. The Escrow Agent is hereby authorized, in its sole discretion, to
comply with orders issued or process entered by any court with respect to the
Escrow Funds, without determination by the Escrow Agent of such court's
jurisdiction in the matter. If any

                                       5
<PAGE>

portion of the Escrow Funds is at any time attached, garnished or levied upon
under any court order, or in case the payment, assignment, transfer, conveyance
or delivery of any such property shall be stayed or enjoined by any court order,
or in any case any order judgment or decree shall be made or entered by any
court affecting such property or any part thereof, then and in any such event,
the Escrow Agent is authorized, in its sole discretion, to rely upon and comply
with any such order, writ judgment or decree which it is advised by legal
counsel selected by it, binding upon it, without the need for appeal or other
action; and if the Escrow Agent complies with any such order, writ, judgment or
decree, it shall not be liable to any of the parties hereto or to any other
person or entity by reason of such compliance even though such order, writ
judgment or decree may be subsequently reversed, modified, annulled, set aside
or vacated.

      11. Indemnification of Escrow Agent. From and at all times after the date
of this Agreement, the parties jointly and severally, shall, to the fullest
extent permitted by law and to the extent provided herein, indemnify and hold
harmless Escrow Agent and each director, officer, employee, attorney, agent and
affiliate of Escrow Agent (collectively, the "Indemnified Parties") against any
and all actions, claims (whether or not valid), losses, damages, liabilities,
costs and expenses of any kind or nature whatsoever (including without
limitation reasonable attorney's fees, costs and expenses) incurred by or
asserted against any of the Indemnified Parties from and after the date hereof,
whether direct, indirect or consequential, as a result of or arising from or in
any way relating to any claim, demand, suit, action, or proceeding (including
any inquiry or investigation) by any person, including without limitation the
parties to this Agreement, whether threatened or initiated, asserting a claim
for any legal or equitable remedy against any person under any statute or
regulation, including, but not limited to, any federal or state securities laws,
or under any common law or equitable cause or otherwise, arising from or in
connection with the negotiation, preparation, execution, performance or failure
of performance of this Agreement or any transaction contemplated herein, whether
or not any such Indemnified Party is a party to any such action or proceeding,
suit or the target of any such inquiry or investigation; provided, however, that
no Indemnified Party shall have the right to be indemnified hereunder for
liability finally determined by a court of competent jurisdiction, subject to no
further appeal, to have resulted solely from the gross negligence or willful
misconduct of such Indemnified Party. If any such action or claim shall be
brought or asserted against any Indemnified Party, such Indemnified Party shall
promptly notify the Company and the Investor hereunder in writing, and the and
the Company shall assume the defense thereof, including the employment of
counsel and the payment of all expenses. Such Indemnified Party shall, in its
sole discretion, have the right to employ separate counsel (who may be selected
by such Indemnified Party in its sole discretion) in any such action and to
participate in the defense thereof, and the fees and expenses of such counsel
shall be paid by such Indemnified Party, except that the Investor and/or the
Company shall be required to pay such fees and expense if (a) the Investor or
the Company agree to pay such fees and expenses, or (b) the Investor and/or the
Company shall fail to assume the defense of such action or proceeding or shall
fail, in the sole discretion of such Indemnified Party, to employ counsel
reasonably satisfactory to the Indemnified Party in any such action or
proceeding, (c) the Investor and the Company are the plaintiff in any such
action or proceeding or (d) the named or potential parties to any such action or
proceeding (including any potentially impleaded parties) include both
Indemnified Party the Company and/or the Investor and Indemnified Party shall
have been advised by counsel that there may be one or more legal defenses
available to it which are different from or additional to those available to the
Company or the Investor. The Investor and the Company shall be jointly

                                       6
<PAGE>

and severally liable to pay fees and expenses of counsel pursuant to the
preceding sentence, except that any obligation to pay under clause (a) shall
apply only to the party so agreeing. All such fees and expenses payable by the
Company and/or the Investor pursuant to the foregoing sentence shall be paid
from time to time as incurred, both in advance of and after the final
disposition of such action or claim. The obligations of the parties under this
section shall survive any termination of this Agreement, and resignation or
removal of the Escrow Agent shall be independent of any obligation of Escrow
Agent.

      12. Expenses of Escrow Agent. Except as set forth in Section 11 the
Company shall reimburse Escrow Agent for all of its reasonable out-of-pocket
expenses, including attorneys' fees, travel expenses, telephone and facsimile
transmission costs, postage (including express mail and overnight delivery
charges), copying charges and the like as outlined in Section 12.4 of the
Standby Equity Distribution Agreement dated the date hereof. All of the
compensation and reimbursement obligations set forth in this Section shall be
payable by the Company, upon demand by Escrow Agent. The obligations of the
Company under this Section shall survive any termination of this Agreement and
the resignation or removal of Escrow Agent.

      13. Warranties.

            a. The Investor makes the following representations and warranties
to the Escrow Agent and Investor's Counsel:

                  i. The Investor has full power and authority to execute and
deliver this Agreement and to perform its obligations hereunder.

                  ii. This Agreement has been duly approved by all necessary
action of the Investor, including any necessary approval of the limited partner
of the Investor, has been executed by duly authorized officers of the Investor's
general partner, enforceable in accordance with its terms.

                  iii. The execution, delivery, and performance of the Investor
of this Agreement will not violate, conflict with, or cause a default under the
agreement of limited partnership of the Investor, any applicable law or
regulation, any court order or administrative ruling or degree to which the
Investor is a party or any of its property is subject, or any agreement,
contract, indenture, or other binding arrangement.

                  iv. Mark A. Angelo has been duly appointed to act as the
representative of Investor hereunder and has full power and authority to
execute, deliver, and perform this Agreement, to execute and deliver any Joint
Written Direction, to amend, modify, or waive any provision of this Agreement,
and to take any and all other actions as the Investor's representative under
this Agreement, all without further consent or direction form, or notice to, the
Investor or any other party.

                  v. No party other than the parties hereto have, or shall have,
any lien, claim or security interest in the Escrow Funds or any part thereof. No
financing statement under the Uniform Commercial Code is on file in any
jurisdiction claiming a security interest in or describing (whether specifically
or generally) the Escrow Funds or any part thereof.

                                       7
<PAGE>

                  vi. All of the representations and warranties of the Investor
contained herein are true and complete as of the date hereof and will be true
and complete at the time of any disbursement from the Escrow Funds.

            b. The Company makes the following representations and warranties to
Escrow Agent and, the Investor:

                  i. The Company is a corporation duly organized, validly
existing, and in good standing under the laws of the State of Delaware, and has
full power and authority to execute and deliver this Agreement and to perform
its obligations hereunder.

                  ii. This Agreement has been duly approved by all necessary
corporate action of the Company, including any necessary shareholder approval,
has been executed by duly authorized officers of the Company, enforceable in
accordance with its terms.

                  iii. The execution, delivery, and performance by the Company
of this Escrow Agreement is in accordance with the Standby Equity Distribution
Agreement and will not violate, conflict with, or cause a default under the
certificate of incorporation or bylaws of the Company, any applicable law or
regulation, any court order or administrative ruling or decree to which the
Company is a party or any of its property is subject, or any agreement,
contract, indenture, or other binding arrangement.

                  iv. Stephen M. Merrick or David G. Kreher have been duly
appointed to act as the representatives of the Company hereunder and have full
power and authority to execute, deliver, and perform this Agreement, to execute
and deliver any Joint Written Direction, to amend, modify or waive any provision
of this Agreement and to take all other actions as the Company's Representatives
under this Agreement, all without further consent or direction from, or notice
to, the Company or any other party.

                  v. No party other than the parties hereto shall have, any
lien, claim or security interest in the Escrow Funds or any part thereof. No
financing statement under the Uniform Commercial Code is on file in any
jurisdiction claiming a security interest in or describing (whether specifically
or generally) the Escrow Funds or any part thereof.

                  vi. All of the representations and warranties of the Company
contained herein are true and complete as of the date hereof and will be true
and complete at the time of any disbursement from the Escrow Funds.

      14. Consent to Jurisdiction and Venue. In the event that any party hereto
commences a lawsuit or other proceeding relating to or arising from this
Agreement, the parties hereto agree that the United States District Court for
the District of New Jersey shall have the sole and exclusive jurisdiction over
any such proceeding. If all such courts lack federal subject matter
jurisdiction, the parties agree that the Superior Court Division of New Jersey,
Chancery Division of Hudson County shall have sole and exclusive jurisdiction.
Any of these courts shall be proper venue for any such lawsuit or judicial
proceeding and the parties hereto waive any objection to such venue. The parties
hereto consent to and agree to submit to the jurisdiction of any of the courts
specified herein and agree to accept the service of process to vest personal
jurisdiction over them in any of these courts.

                                       8
<PAGE>

      15. Notice. All notices and other communications hereunder shall be in
writing and shall be deemed to have been validly served, given or delivered five
(5) days after deposit in the United States mail, by certified mail with return
receipt requested and postage prepaid, when delivered personally, one (1) day
delivery to any overnight courier, or when transmitted by facsimile transmission
and addressed to the party to be notified as follows:

If to Investor, to:              Cornell Capital Partners, LP
                                 101 Hudson Street - Suite 3606
                                 Jersey City, NJ 07302
                                 Attention:    Mark Angelo
                                 Facsimile:    (201) 985-8266

If to Escrow Agent, to:          Butler Gonzalez LLP
                                 1000 Stuyvesant Avenue - Suite 6
                                 Union, NJ 07083
                                 Attention:    David Gonzalez, Esq.
                                 Facsimile:    (908) 810-0973

If to Company, to:               Reliv' International Inc.
                                 136 Chesterfield Industrial Blvd.
                                 Chesterfield, MO 63005
                                 Attention:    Stephen M. Merrick
                                 Telephone:    (636) 537-8907
                                 Facsimile:    (847) 483-1265

With a copy to:                  Merrick & Klimek
                                 33 N. LaSalle Street
                                 Chicago, IL 60602
                                 Attention:    John M. Klimek, Esq.
                                 Telephone:    (312) 284-1520
                                 Facsimile:    (312) 284-1521

      Or to such other address as each party may designate for itself by like
notice.

      16. Amendments or Waiver. This Agreement may be changed, waived,
discharged or terminated only by a writing signed by the parties of the Escrow
Agent. No delay or omission by any party in exercising any right with respect
hereto shall operate as waiver. A waiver on any one occasion shall not be
construed as a bar to, or waiver of, any right or remedy on any future occasion.

      17. Severability. To the extent any provision of this Agreement is
prohibited by or invalid under applicable law, such provision shall be
ineffective to the extent of such prohibition, or invalidity, without
invalidating the remainder of such provision or the remaining provisions of this
Agreement.

                                       9
<PAGE>

      18. Governing Law. This Agreement shall be construed and interpreted in
accordance with the internal laws of the State of Delaware without giving effect
to the conflict of laws principles thereof.

      19. Entire Agreement. This Agreement constitutes the entire Agreement
between the parties relating to the holding, investment, and disbursement of the
Escrow Funds and sets forth in their entirety the obligations and duties of the
Escrow Agent with respect to the Escrow Funds.

      20. Binding Effect. All of the terms of this Agreement, as amended from
time to time, shall be binding upon, inure to the benefit of and be enforceable
by the respective heirs, successors and assigns of the Investor, the Company, or
the Escrow Agent.

      21. Execution of Counterparts. This Agreement and any Joint Written
Direction may be executed in counter parts, which when so executed shall
constitute one and same agreement or direction.

      22. Termination. Upon the first to occur of the termination of the Standby
Equity Distribution Agreement dated the date hereof or the disbursement of all
amounts in the Escrow Funds and Common Stock into court pursuant to Section 7
hereof, this Agreement shall terminate and Escrow Agent shall have no further
obligation or liability whatsoever with respect to this Agreement or the Escrow
Funds or Common Stock.

                  [REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

                                       10
<PAGE>

            IN WITNESS WHEREOF the parties have hereunto set their hands and
      seals the day and year above set forth.

                                         RELIV' INTERNATIONAL INC.

                                         By:  /s/ Robert L. Montgomery
                                            -----------------------------------
                                         Name:   Robert L. Montgomery
                                         Title:  Chief Executive Officer

                                         CORNELL CAPITAL PARTNERS, LP

                                         By:      Yorkville Advisors, LLC
                                         Its:     General Partner

                                         By:  /s/ Mark A. Angelo
                                            -----------------------------------
                                         Name:    Mark A. Angelo
                                         Title:   Portfolio Manager

                                         BUTLER GONZALEZ LLP

                                         By:  /s/ David Gonzalez
                                            -----------------------------------
                                         Name:    David Gonzalez, Esq.
                                         Title:   Partner

                                       11Amended and Restated Investor Rights Agreement dated May 31, 2001

 EXHIBIT 4.2 

  
 AMENDED AND RESTATED
INVESTOR RIGHTS AGREEMENT 
  
 BY AND AMONG 
  
 CALLWAVE, INC. 
  
 AND 
  
 THE INVESTORS NAMED HEREIN 
  
 DATED AS OF MAY 31, 2001 
  

 AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT 
  
 THIS AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (the
“Agreement”) dated for reference purposes as of May 31, 2001, by and among CALLWAVE, INC., a California corporation (the “Company”) and the holders of the Company’s Series
A Preferred Stock listed on Schedule A hereto (the “SERIES A HOLDERS”), the holders of the Company’s Series B Preferred Stock listed on Schedule B hereto (the
“SERIES B HOLDERS”), the holders of the Company’s Series C Preferred Stock listed on Schedule C hereto (the “SERIES C
HOLDERS”), the holders of the Company’s Series D Preferred Stock listed on Schedule D hereto (the “SERIES D HOLDERS”), and the holders of the
Company’s Series E Preferred Stock listed on Schedule E hereto (the “SERIES E HOLDERS”) (each of the Series A Holders, the Series B Holders, the Series C Holders, the Series D
Holders, and the Series E Holders individually is referred to as an “INVESTOR” and collectively are referred to as the “INVESTORS”), with reference to the
following facts: 
  
 RECITALS: 
  
 A. The Company previously issued to certain Investors shares of the
Company’s Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, and Series D Preferred Stock, and in connection with such issuance the Company, the Series A Holders, the Series B Holders, the Series C Holders, and the
Series D Holders executed that certain Prior Rights Agreement (as defined below), pursuant to which the Company granted certain registration and other rights to the Series A Holders, the Series B Holders, the Series C Holders, and the Series D
Holders. 
  
 B. Concurrently with the execution of this Agreement,
the Series E Holders are purchasing from the Company certain shares of the Company’s Series E Preferred Stock, and the Company has agreed to execute and deliver this Agreement to the Series E Holders in order to grant to them certain
registration and other rights with respect to their shares of Series E Preferred Stock. 
  
 C. The Parties have agreed to execute this Agreement in order to amend, restate and supersede the Investors Rights Agreement and to memorialize the terms and conditions on which the Company shall grant to all
Investors certain registration and other rights with respect to the Company’s outstanding shares of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, and Series E Preferred Stock.

  
 AGREEMENTS: 
  
 NOW, THEREFORE, the parties hereto, intending to be legally bound, do
hereby agree as follows: 
  
 1. DEFINITIONS. For purposes of
this Agreement, the term: 
  
 1.1
“Act” means the Securities Act of 1933, as amended. 
  
 1.2 “Common Stock” means the common capital stock of the Company. 
  
 1.3 “Common Stock Equivalents” means the Company’s Common Stock then outstanding plus the shares of Common Stock then
issuable upon conversion of the Company’s then outstanding Preferred Stock. 
  

 -1- 

 1.4 “Form S-3” means such form under the Act as in effect on the date
hereof or any registration form under the Act subsequently adopted by the United States Securities and Exchange Commission (the “SEC”) which permits inclusion or incorporation of substantial information by reference to other documents
filed by the Company with the SEC. 
  
 1.5
“Holder” means each Investor and each additional person who purchases any shares of this Company’s Preferred Stock and executes this Agreement. 
  
 1.6 “Preferred Stock” means, collectively, the Company’s (i) Series A Preferred Stock,
(ii) Series B Preferred Stock, (iii) Series C Preferred Stock, (iv) Series D Preferred Stock, and (v) Series E Preferred Stock. 
  
 1.7 “Prior Rights Agreement” means that certain “Investor Rights Agreement” dated effective June 26, 2000, by and
among the Company and the Series A Holders, the Series B Holders, the Series C Holders, and the Series D Holders. 
  
 1.8 “Register,” “Registered,” and “Registration” mean a registration effected by preparing and filing
with the SEC a registration statement or similar document in compliance with the Act, and the SEC’s declaring or ordering of effectiveness of such registration statement or document. 
  
 1.9 “Qualified Initial Public Offering” means an underwritten public offering of shares of
the Company’s capital stock pursuant to an effective registration statement filed under the Act, pursuant to which the Company has (i) generated at least Ten Million Dollars ($10,000,000) of gross offering proceeds, (ii) sold its shares in such
offering at a price per share that is (x) at least Five Dollars ($5.00) per share, and (y) at least equal to the product of (A) four and seventeen hundredths (4.17), multiplied times (B) the Series D original purchase price of $2.40 per share
(as adjusted for stock splits with respect to such shares). 
  
 1.10 “Registrable Securities” means (i) the Common Stock issuable or issued upon conversion of the Preferred Stock, (ii) any Common Stock of the Company issued as (or issuable upon the conversion or exercise
of any warrant, right or other security which is issued as) a dividend or other distribution with respect to, or in exchange for or in replacement of, such Preferred Stock, and (iii) shares of Common Stock issuable upon exercise of warrants granted
in connection with promissory notes issued by the Company, to the extent the Board of Directors elects to grant to the holders of such warrants the registration rights granted in this Agreement. 
  
 1.11 “Registrable Securities then outstanding”
means the shares of Common Stock outstanding which are, and the number of shares of Common Stock issuable pursuant to exercisable or convertible securities which are, Registrable Securities. 
  
 2. REGISTRATION RIGHTS 
  
 The Company covenants and agrees as follows: 
  
 2.1 Requested Registration. If the Company shall receive at
any time after the earlier of (i) April 30, 2002, or (ii) nine (9) months after the effective date of the first registration statement for a public offering of securities of the Company (other than a registration statement relating either to the
sale of securities to employees of the Company pursuant to a stock option, stock purchase or similar plan or an SEC Rule 145 
  

 -2- 

 transaction), a written request from the Holders of at least twenty-five percent (25.0%) of the Company’s
Registrable Securities then outstanding (including all shares of Common Stock into which such shares of Preferred Stock and then may have been converted) that the Company file a registration statement under the Act covering the registration of
Registrable Securities, then the Company shall, within ten (10) days of the receipt thereof, give written notice of such request to all Holders and shall, subject to the limitations of Section 2.1.1, below, use its diligent best efforts to effect as
soon as practicable, the registration under the Act of all Registrable Securities which the Holders request to be registered within twenty (20) days of the mailing of such written notice by the Company. 
  
 2.1.1 Exceptions. However, the Company shall not be
obligated to take any action to effect any such registration, qualification or compliance pursuant to this Section 2.1: 
  
 A. If the minimum aggregate offering price of the Registrable Securities requested to be registered pursuant to such registration by all of the Holders
is less than One Million Dollars ($1,000,000); 
  
 B. If the
Company has effected two (2) such registrations pursuant to this Section 2.1, and such registrations have been declared or ordered effective; or 
  
 C. If the Company shall furnish to such Holders a certificate signed by the President of the Company stating that in the good faith judgment of the Board
of Directors (or underwriters then engaged by the Company to conduct an offering within one hundred and eighty (180) days following the date of the Holders’ request hereunder) such requested registration, if implemented, would have a material
adverse impact upon the Company or its stockholders, then the Company’s obligation to use its best efforts to register, qualify or comply under this Section 2.1 shall be deferred for a period not to exceed ninety (90) days from the date of
receipt of written request from the Holders; provided, however, that the Company may not utilize this right more than once in any twelve-month period. 
  
 2.1.2 Underwriting. If the Holders initiating the registration request hereunder (the “Initiating
Holders”) intend to distribute the Registrable Securities covered by their request by means of an underwriting, they shall so advise the Company as a part of their request made pursuant to this Section 2.1 and the Company shall include such
information in the written notice referred to in Section 2.1, above. In such event, the right of any Holder to include his Registrable Securities in such registration shall be conditioned upon such Holder’s participation in the underwriting
arrangements required by this Section 2.1, and the inclusion of such Holder’s Registrable Securities in the underwriting (unless otherwise mutually agreed by a majority in interest of the Initiating Holders and such Holder) shall be limited to
the extent provided herein. 
  
 A. All Holders proposing to
distribute their securities through such underwriting shall (together with the Company) enter into an underwriting agreement in customary form with the underwriter or underwriters selected for such underwriting by a majority in interest of the
Initiating Holders, provided that such underwriting agreement shall not provide for indemnification or contribution obligations on the part of the Holders greater than the obligations set forth in Section 2.8.2. Notwithstanding any other provision
of this Section 2.1, if the managing underwriter advises the Initiating Holders in writing that marketing factors require a limitation of the number of shares to be underwritten, then the Company shall so advise all holders of Registrable Securities
and the number of shares of Registrable Securities that may be included in the registration and underwriting shall be allocated among all Holders of Registrable Securities in proportion, as nearly as practicable, to the respective amounts of
Registrable Securities held by such Holders at the time of filing the registration statement or in such other manner as shall be agreed to by the Holders of a majority of the Registrable Securities 
  

 -3- 

 proposed to be included in such registration, until all of the Registrable Securities proposed to be included in such
registration are included in such registration. No Registrable Securities excluded from the underwriting by reason of the underwriter’s marketing limitation shall be included in such registration. To facilitate the allocation of shares in
accordance with the above provisions, the Company or the underwriters may round the number of shares allocated to any Holder to the nearest one hundred (100) shares. 
  
 B. If any Holder of Registrable Securities disapproves of the terms of the underwriting, such person may elect to withdraw
therefrom by written notice to the Company, the managing underwriter and the Initiating Holders. The Registrable Securities and/or other securities so withdrawn shall also be withdrawn from registration, and such Registrable Securities shall not be
transferred in a public distribution prior to 90 days after the effective date of such registration, or such other shorter period of time as the underwriters may require. 
  
 2.2 Company Registration. If the Company proposes to register (including for this purpose a
registration effected by the Company for stockholders other than the Holders) any of its stock or other securities under the Act in connection with the public offering of such securities solely for cash (other than a registration relating solely to
the sale of securities to participants in a Company stock plan, or a registration on any form which does not include substantially the same information as would be required to be included in a registration statement covering the sale of the
Registrable Securities, or a registration relating solely to a corporate reorganization or other similar Rule 145 transaction on Form S-4 or any similar form promulgated in the future), then the Company shall, at such time, promptly give each Holder
written notice of such registration. 
  
 2.2.1 Request by
Holder. Upon the written request of each Holder given within twenty (20) days after mailing of the written notice described in Section 2.2, above, by the Company, the Company shall cause to be registered under the Act all of the Registrable
Securities that each such Holder has requested to be registered. 
  
 2.2.2 Underwriting. If the registration of which the Company gives notice is for a registered public offering involving an underwriting, the Company shall so advise the Holders as a part of the written notice given pursuant to
Section 2.2. In such event the right of any Holder to registration pursuant to this Section 2.2 shall be conditioned upon such Holder’s participation in such underwriting and the inclusion of Registrable Securities in the underwriting to the
extent provided herein. All Holders proposing to distribute their securities through such underwriting shall (together with the Company and the other Holders distributing their securities through such underwriting) enter into an underwriting
agreement in customary form with the managing underwriter selected for such underwriting by the Company, provided that such underwriting agreement shall not provide for indemnification or contribution obligations on the part of the Holders greater
than the obligations set forth in Section 2.8.2. Notwithstanding any other provision of this Section 2.2, if the managing underwriter determines that marketing factors require a limitation of the number of shares to be underwritten, the managing
underwriter may limit the Registrable Securities or other securities to be included in such registration; provided, however, that no such reduction shall reduce the amount of securities of the selling Holders included in the
registration below five percent (5.0%) of the total amount of securities included in such registration, unless such offering is the initial public offering and the registration does not include shares of any other selling shareholders, in which
event any or all of the Registrable Securities of the Holders may be excluded; provided, further, that if the number of shares of Registrable Securities permitted to be registered is reduced pursuant to the preceding sentence, then no
persons may sell securities in such offering except for the Company and the Holders of Registrable Securities. 
  

 -4- 

 A. The Company shall so advise all Holders and other holders distributing their securities through such
underwriting and the number of shares of Registrable Securities and other securities that may be included in the registration, and underwriting shall be allocated among all Holders in proportion, as nearly as practicable, to the respective amounts
of Registrable Securities held by such Holders at the time of filing the registration statement. To facilitate the allocation of shares in accordance with the above provisions, the Company may round the number of shares allocated to any Holder or
holder to the nearest 100 shares. 
  
 B. If any Holder
disapproves of the terms of any such underwriting, he may elect to withdraw therefrom by written notice to the Company and the managing underwriter. Any securities excluded or withdrawn from such underwriting shall be withdrawn from such
registration, and shall not be transferred in a public distribution prior to 90 days after the effective date of the registration statement relating thereto, or such other shorter period of time as the underwriters may require. 
  
 2.3 Form S-3 Registration. 
  
 2.3.1 Request for Registration. After its initial public
offering, the Company shall use its best efforts to qualify for registration on Form S-3 or any comparable or successor form or forms. After the Company has qualified for the use of Form S-3, in addition to the rights contained in the foregoing
portions of this Section 2, if any Holder or Holders request that the Company effect a registration on Form S-3 and any related or successor qualification or compliance with respect to all or a part of the Registrable Securities owned by such Holder
or Holders, the Company shall promptly give written notice of the proposed registration, and any related qualification or compliance, to all other Holders. Upon the written request of each Holder given within twenty (20) days after mailing of
written notice by the Company, the Company shall effect such registration and all such qualifications and compliance as may be so requested and as would permit or facilitate the sale and distribution of all or such portion of such Holder’s or
Holders’ Registrable Securities. Registrations effected pursuant to this Section 2.3 shall not be counted as demands for registration or registrations effected pursuant to Section 2.1, above. 
  
 2.3.2 Exceptions. Notwithstanding the foregoing, the Company
shall not be obligated to take any action to effect any such registration, qualification or compliance pursuant to this Section 2.3: 
  
 A. If the Holders, together with the holders of any other securities of the Company entitled to inclusion in such registration, propose to sell
Registrable Securities and such other securities (if any) at an aggregate price to the public of less than Five Hundred Thousand Dollars ($500,000); 
  
 B. If the Company has already effected two (2) such registrations pursuant to this Section 2.3 within such twelve-month period, and such registrations
have been declared or ordered effective; or 
  
 C. If the Company
shall furnish to such Holders a certificate signed by the President of the Company stating that in the good faith judgment of the Board of Directors it would be seriously detrimental to the Company or its shareholders for a registration statement to
be filed at such time, then the Company’s obligation to use its best efforts to register, qualify or comply under this Section 2.3 shall be deferred for a period not to exceed ninety (90) days from the date of receipt of written request from
the Holders; provided, however, that the Company may not utilize this right more than once in any twelve-month period. 
  

 -5- 

 2.4 Obligations of the Company. Whenever required under this Section 2 to effect the
registration of any Registrable Securities, the Company shall, as expeditiously as reasonably possible: 
  
 2.4.1 Prepare and file with the SEC a registration statement with respect to such Registrable Securities and use its best efforts to cause such
registration statement to become effective, and, upon the request of the Holders of a majority of the Registrable Securities registered thereunder, keep such registration statement effective for up to one hundred twenty (120) days. 
  
 2.4.2 Prepare and file with the SEC such amendments and supplements to
such registration statement and the prospectus used in connection with such registration statement as may be necessary to comply with the provisions of the Act with respect to the disposition of all securities covered by such registration statement.

  
 2.4.3 Furnish to the Holders such numbers of copies of
a prospectus, including a preliminary prospectus, in conformity with the requirements of the Act, and such other documents as they may reasonably request in order to facilitate the disposition of Registrable Securities owned by them. 
  
 2.4.4 Use its best efforts to register and qualify the securities
covered by such registration statement under such other securities or Blue Sky laws of such jurisdictions as shall be reasonably requested by the Holders, provided that the Company shall not be required in connection therewith or as a condition
thereto to qualify to do business or to file a general consent to service of process in any such states or jurisdictions. 
  
 2.4.5 In the event of any underwritten public offering, enter into and perform its obligations under an underwriting agreement, in usual and
customary form, with the managing underwriter of such offering. 
  
 2.4.6 Notify each Holder of Registrable Securities covered by such registration statement at any time when a prospectus relating thereto is required to be delivered under the Act of the happening of any event as a result of which the
prospectus included in such registration statement, as then in effect, includes an untrue statement of a material fact or omits to state a material fact required to be stated therein or necessary to make the statements therein not misleading in the
light of the circumstances then existing. 
  
 2.4.7
Furnish, at the request of any Holder requesting registration of Registrable Securities pursuant to this Section 2, on the date that such Registrable Securities are delivered to the underwriters for sale in connection with a registration
pursuant to this Section 2, if such securities are being sold through underwriters, or, if such securities are not being sold through underwriters, on the date that the registration statement with respect to such securities becomes effective, an
opinion, dated such date, of the counsel representing the Company for the purposes of such registration, and a letter dated as of such date, from the independent certified public accountant of the Company, each in form and substance as is
customarily given to underwriters in an underwritten public offering, addressed to the underwriters, if any, and to the Holders requesting registration of Registrable Securities. 
  
 2.5 Furnish Information. It shall be a condition precedent to the obligations of the Company to take any
action pursuant to this Section 2 with respect to the Registrable Securities of any selling Holder that such Holder shall furnish to the Company such information regarding itself, the Registrable Securities held by it, and the intended method of
disposition of such securities as shall be required to effect the registration of such Holder’s Registrable Securities. 
  

 -6- 

 2.6 Expenses of Demand and Company Registration. The Company shall bear and pay:

  
 2.6.1 Demand Registration. All expenses (other
than underwriting discounts and commissions, which shall be paid out of the gross proceeds of such underwritten offering) including quoting in connection with registrations, filings, or qualifications pursuant to Section 2.1, above, including
(without limitation) all registration, filing and qualification fees, printers’ and accounting fees, and fees and disbursements of accounts for the Company and reasonable fees of one special counsel selected by the Selling Holders; provided,
however, that the Company shall not be required to pay for any expenses of any registration proceeding initiated pursuant to Section 2.1, above, if the registration request is subsequently withdrawn at the request of the Holders of the majority
of the Registrable Securities to be registered therein (in which case all participating Holders shall bear such expenses), unless the Holders of the majority of the Registrable Securities agree to forfeit their right to a demand registration
pursuant to Section 2.1, above; provided further, however, that if at the time of such withdrawal, the Holders have learned of a material adverse change in the condition, business, or prospects of the Company not known to the Holders at the
time of their request, then such Holders shall not be required to pay any such expenses and shall retain their rights to initiate registration pursuant to Section 2.1, above. 
  
 2.6.2 Company Registration. All expenses incurred in connection with any registration, filing or qualification
of Registrable Securities with respect to registrations pursuant to Section 2.2, above, for each Holder, including (without limitation) all registration, filing, and qualification fees, printers and accounting fees relating or apportionable thereto,
and the fees and disbursements of counsel for the selling Holders selected by them, including reasonable fees of one special counsel selected by the selling Holders, but excluding underwriting discounts and commissions relating to Registrable
Securities. 
  
 2.7 Expenses of S-3 Registration.
For the first two (2) registrations pursuant to Section 2.3, above, all expenses, including (without limitation) underwriting discounts and commissions incurred in connection with registrations, filings or qualifications pursuant to Section 2.3,
the fees and disbursements of counsel selected by the selling Holders, all registration, filing and qualification fees, printers’ and accounting fees, and fees and disbursements of counsel for the Company shall be borne by the Company,
thereafter such expenses shall be borne pro rata by the selling Holders (except for the fees of Company counsel and the Company’s accounting fees which shall be paid by the Company) in proportion, as nearly as practicable, to the respective
amounts of Registrable Securities being sold by such Holders pursuant to such registration. 
  
 2.8 Indemnification. In the event any Registrable Securities are included in a registration statement under this Section 2: 
  
 2.8.1 Indemnity by Company. To the extent permitted by law, the Company will indemnify and hold harmless each
Holder, the employees, officers, directors, agents and partners of such Holder, any underwriter (as defined in the Act) for such Holder and each person, if any, who controls such Holder or underwriter within the meaning of the Act or the Securities
Exchange Act of 1934, as amended (the “1934 Act”), against any losses, claims, damages, or liabilities (joint or several) to which they may become subject under the Act, the 1934 Act or other federal or state law, insofar as such losses,
claims, damages, or liabilities (or actions in respect thereof) arise out of or are based upon any of the following statements, omissions or violations (collectively a “Violation”): (i) any untrue statement or alleged untrue statement of a
material fact contained in such registration statement, including any preliminary prospectus or final prospectus contained therein or any amendments or supplements thereto, (ii) the omission or alleged omission to state therein a material fact
required to be stated therein, or necessary to make the statements therein not misleading, or (iii) any violation or alleged violation by the Company of the Act, the 1934 Act, any state securities law or any rule or regulation promulgated under the
Act, the 1934 Act or any state securities law; and the Company will pay to each such Holder, the officers, directors and partners of a Holder, underwriter or controlling person, as incurred, any legal or other 
  

 -7- 

 expenses reasonably incurred by them in connection with investigating or defending any such loss, claim, damage,
liability, or action; provided, however, that the indemnity agreement contained in this Section 2.8.1 shall not apply to amounts paid in settlement of any such loss, claim, damage, liability, or action if such settlement is
effected without the consent of the Company (which consent shall not be unreasonably withheld), nor shall the Company be liable in any such case for any such loss, claim, damage, liability, or action to the extent that it arises out of or is based
upon a Violation which occurs in reliance upon and in conformity with written information furnished expressly for use in connection with such registration by any such Holder, underwriter or controlling person. 
  
 2.8.2 Indemnity by Holder. To the extent permitted by law, each
selling Holder will indemnify and hold harmless the Company, each of its directors, each of its officers who has signed the registration statement, each person, if any, who controls the Company within the meaning of the Act, any underwriter, any
other Holder selling securities in such registration statement and any controlling person of any such underwriter or other Holder, against any losses, claims, damages, or liabilities (joint or several) to which any of the foregoing persons may
become subject, under the Act, the 1934 Act, or other federal or state law, insofar as such losses, claims, damages, or liabilities (or actions in respect thereto) arise out of or are based upon any Violation, in each case to the extent (and only to
the extent) that such Violation occurs in reliance upon and in conformity with written information furnished by such Holder expressly for use in connection with such registration; and each such Holder will pay, as incurred, any legal or other
expenses reasonably incurred by any person intended to be indemnified pursuant to this Section 2.8.2, in connection with investigating or defending any such loss, claim, damage, liability, or action; provided, however, that the
indemnity agreement contained in this Section 2.8.2 shall not apply to amounts paid in settlement of any such loss, claim, damage, liability or action if such settlement is effected without the consent of the Holder, which consent shall not be
unreasonably withheld; provided, that, in no event shall the total amount of any indemnity under this Section 2.8.2 exceed the net proceeds from the offering received by such Holder. 
  
 2.8.3 Indemnity Procedure. Promptly after receipt by an
indemnified party under this Section 2.8 of notice of the commencement of any action (including any governmental action), such indemnified party will, if a claim in respect thereof is to be made against any indemnifying party under this Section 2.8,
deliver to the indemnifying party a written notice of the commencement thereof and the indemnifying party shall have the right to participate in, and, to the extent the indemnifying party so desires, jointly with any other indemnifying party
similarly noticed, to assume the defense thereof with counsel mutually satisfactory to the parties; provided, however, that an indemnified party shall have the right to retain its own counsel, with the fees and expenses to be
paid by the indemnifying party, if representation of such indemnified party by the counsel retained by the indemnifying party would be inappropriate due to actual or potential differing interests between such indemnified party and any other party
represented by such counsel in such proceeding. The failure to deliver written notice to the indemnifying party within a reasonable time of the commencement of any such action, if materially prejudicial to its ability to defend such action, shall
relieve such indemnifying party of any liability to the indemnified party under this Section 2.8, but the omission so to deliver written notice to the indemnifying party will not relieve it of any liability that it may have to any indemnified party
otherwise than under this Section 2.8. 
  
 2.8.4
Contribution. In order to provide for just and equitable contribution to joint liability under the Act in any case in which either (i) any Holder exercising rights under this Agreement, or any controlling person of any such Holder, makes
a claim for indemnification pursuant to this Section 2.8 but it is judicially determined (by the entry of a final judgment or decree by a court of competent jurisdiction and the expiration of time to appeal or the denial of the last right of appeal)
that such indemnification may not be enforced in such case notwithstanding the fact that this Section 2.8 provides for indemnification in such case, or (ii) contribution under 
  

 -8- 

 the Act may be required on the part of any such selling Holder or any such controlling person in circumstances for which
indemnification is provided under this Section 2.8; then, and in each such case, the Company and such Holder will contribute to the aggregate losses, claims, damages or liabilities to which they may be subject (after contribution from others) in
such proportion, so that the Holder is responsible for and shall contribute to the amount paid or payable by such Indemnified Party as a result of such loss, liability, claim, damage or expense in such proportion as is appropriate to reflect the
relative fault of the Indemnifying Party on the one hand and of the Indemnified Party on the other in connection with the statements or omissions which resulted in such loss, liability, claim, damage or expense as well as any other relevant
equitable considerations. The relative fault of the Indemnifying Party and of the Indemnified Party shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission to state a
material fact relates to information supplied by the Indemnifying Party or by the Indemnified Party and the party’s relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission. The Company
and other selling Holders are responsible for the remaining portion, provided, however, that, in any such case, (A) no such Holder will be required to contribute any amount in excess of the public offering price of all such
Registrable Securities offered and sold by such Holder pursuant to such registration statement; and (B) no person or entity guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Act) will be entitled to contribution from
any person or entity who was not guilty of such fraudulent misrepresentation. 
  
 2.8.5 Survival. The obligations of the Company and Holders under this Section 2.8 shall survive the completion of any offering of Registrable Securities in a registration statement under this Section 2,
and otherwise. 
  
 2.9 Reports Under Securities Exchange Act
of 1934. With a view to making available to the Holders the benefits of Rule 144 promulgated under the Act and any other rule or regulation of the SEC that may at any time permit a Holder to sell securities of the Company to the public
without registration or pursuant to a registration on Form S-3, the Company agrees to: 
  
 2.9.1 Make and keep public information available, as those terms are understood and defined in SEC Rule 144, at all times after one hundred eighty (180) days after the effective date of the first registration
statement filed by the Company for the offering of its securities to the general public; 
  
 2.9.2 Take such action, including the voluntary registration of its Common Stock under Section 12 of the 1934 Act, as is necessary to enable the Holders to utilize Form S-3 for the sale of their Registrable
Securities, such action to be taken as soon as practicable after the end of the fiscal year in which the first registration statement filed by the Company for the offering of its securities to the general public is declared effective; 
  
 2.9.3 File with the SEC in a timely manner all reports and other
documents required of the Company under the Act and the 1934 Act; and 
  
 2.9.4 Furnish to any Holder, so long as the Holder owns any Registrable Securities, forthwith upon request (i) a written statement by the Company that it has complied with the reporting requirements of SEC Rule 144 (at any time after
one hundred eighty (180) days after the effective date of the first registration statement filed by the Company), the Act and the 1934 Act (at any time after it has become subject to such reporting requirements), or that it qualifies as a registrant
whose securities may be resold pursuant to Form S-3 (at any time after it so qualifies), (ii) a copy of the most recent annual or quarterly report of the Company and 
  

 -9- 

 such other reports and documents so filed by the Company, and (iii) such other information as may be reasonably requested
in availing any Holder of any rule or regulation of the SEC which permits the selling of any such securities without registration or pursuant to such form. 
  
 2.10 “Market Stand-Off” Agreement. Each Holder of Registrable Securities hereby agrees that, during such period as is determined
by the Company’s underwriters (not to exceed 180 days following the effective date of the first registration statement filed by the Company under the Act covering Common Stock (or other securities) to be sold on the Company’s behalf to the
public in an underwritten initial public offering), it shall not, to the extent requested by the Company, sell or otherwise transfer or dispose of (other than to a donee who agrees to be similarly bound) any Common Stock of the Company held by it at
any time during such period except Common Stock included in such registration; provided, however, that each officer and director of the Company and each holder of one percent (1.0%) or more of the Company’s outstanding
equity securities enters into a similar agreement. In order to enforce the foregoing covenants, the Company may impose stop-transfer instructions with respect to the Registrable Securities of each Holder (and the shares or securities of every other
person subject to the foregoing restriction) until the end of any such period. 
  
 2.11 Waivers and Amendments of Registration Rights. Any term of this Section 2 may be amended and the observance of any term of this Section 2 may be waived (either generally or in a particular instance
and either retroactively or prospectively), only with the written consent of the Company and the Holders of at least a majority of the shares of Registrable Securities then outstanding. Any amendment or waiver effected in accordance with this
Section 2.11 shall be binding upon the Company and each Holder of rights under this Section 2. 
  
 2.12 Termination of Registration Rights. No Holder shall be entitled to exercise any right provided for in this Section 2 after (i) five (5) years following the consummation of the sale of securities
pursuant to a registration statement filed by the Company under the Act in connection with the initial firm commitment underwritten offering of its securities to the general public, or (ii) the first date as of which Holder may sell all of Holders
of Registrable Securities within any period of ninety (90) consecutive days pursuant to Rule 144. 
  
 3. CERTAIN COVENANTS OF THE COMPANY 
  
 3.1 Information and Inspection Rights. Subject to Section 3.2, below: 
  
 3.1.1 The Company shall provide to each Holder the following information: 
  
 A. As soon as practicable after the end of each fiscal year, and in any event within ninety (90) days thereafter, a
consolidated balance sheet of the Company and its subsidiaries, if any, as of the end of such fiscal year, and consolidated statements of income, stockholders’ equity and cash flows of the Company and its subsidiaries, if any, for such year,
prepared in accordance with generally accepted accounting principles consistently applied and setting forth in each case in comparative form the figures for the previous fiscal year, all in reasonable detail and audited by independent public
accountants selected by the Company; 
  
 B. As soon as
practicable after the end of each quarter, and in any event within forty-five (45) days thereafter, a consolidated balance sheet of the Company and its subsidiaries, if any, as of the end of each such quarter, consolidated statements of income and
cash flows of the Company and its subsidiaries, if any, for such quarter, and setting forth in each case in comparative form the figures for corresponding periods in the previous fiscal year, prepared in accordance with generally accepted accounting
principles (other than for accompanying notes), subject to changes resulting from year-end audit adjustments, all in reasonable detail and signed by the principal financial or accounting officer of the Company; and 
  

 -10- 

 C. As soon as it is available, but in any event within thirty (30) days prior to the end of the current
fiscal year, an annual financial and business plan for the next fiscal year of the Company containing profit and loss projections, cash flow projections, and capital expenditures, all on a monthly basis. 
  
 3.1.2 The rights granted pursuant to Section 3.1.1, above, may be
assigned or otherwise transferred by the Holder or by any subsequent transferee only to an assignee who acquires sufficient shares of Preferred Stock so as to hold, in the aggregate, at least fifteen percent (15.0%) of the number of shares of
Preferred Stock then outstanding. 
  
 3.1.3 The foregoing
covenants set forth in this Section 3.1 shall terminate and be of no further force or effect upon the closing of a Qualified Initial Public Offering. 
  
 3.2 Confidentiality. Except with the prior written consent of the Company, each Holder receiving information from the Company
pursuant to Section 3.1, above, shall not (i) disclose such information to any person without the prior written consent of the Company (which consent may be withheld in the absolute discretion of the Company), and (ii) shall not use such information
for any purpose other than in evaluating such person’s investment in the Company. The foregoing covenant shall not apply to any information which becomes generally available to the public other than by reason of Holder’s breach of its
obligations under this Section 3.2. 
  
 3.3
Reservation of Common Stock. The Company shall at all times reserve and keep available, solely for issuance and delivery upon the conversion of the Shares, all Common Stock issuable from time to time upon such conversion.

  
 4. MISCELLANEOUS PROVISIONS 
  
 4.1 Notices. All notices, requests, demands or other
communications permitted or required under this Agreement shall be effective only if in writing, and shall be deemed to have been given, received and delivered (a) when personally delivered; (b) on the third (3rd) business day after the date on which it was deposited by certified or registered United States mail, return receipt requested, postage prepaid; (c)
on the date on which transmitted by facsimile or other electronic means generating a receipt evidencing a successful transmission (provided that, on that same date, a copy of such notice is sent by registered or certified mail, postage prepaid,
return receipt requested), or (d) on the next business day after the day on which deposited with a public carrier regulated under United States laws (e.g., Federal Express) for overnight delivery, with a return receipt (or equivalent thereof
administered by such regulated public carrier) requested, in a sealed envelope addressed to the party for whom intended at the address or facsimile number set forth on the signature page of this Agreement or such other address or facsimile number,
notice of which is given in a manner permitted by this Section 4.1. 
  
 4.2 Descriptive Headings. The descriptive headings herein have been inserted for convenience only and shall not be deemed to limit or otherwise affect the construction of any provisions hereof. 
  
 4.3 Arbitration. All disputes arising under or in
connection with this Agreement and transactions contemplated herein shall be resolved through binding arbitration, before a single arbitrator, in the City of Santa 
  

 -11- 

 Barbara, California, under the rules then obtaining of the American Arbitration Association. the decision of the
arbitrator shall be final and binding on the parties hereto, and judgment thereon may be entered in a court of competent jurisdiction. 
  
 4.4 Governing Law; Jurisdiction; Venue. This Agreement shall be governed by and interpreted under the laws of the State of California
as applied to agreements among California residents, made and to be performed entirely within the State of California. Subject to Section 4.3, above, the exclusive venue for all disputes hereunder shall be the Superior Court in and for Santa Barbara
County. Each party hereto consents to the jurisdiction of the courts of the State of California, and waives any objection that such venue shall be in any way inconvenient or otherwise objectionable. 
  
 4.5 Counterparts. This Agreement may be executed in two or more
counterparts, each of which shall for all purposes be deemed to be an original and all of which shall constitute the same instrument, binding on each signatory thereto. The parties acknowledge and agree that after the execution hereof by the Series
A Holders, the Series B Holders, the Series C Holders, the Series D Holders and the Series E Holders initially executing this Agreement: 
  
 4.5.1 Additional Closings for Series E Offering. The Company intends to conduct one or more closings of the sale of shares of
Series E Preferred Stock, pursuant to the Series E Preferred Stock Purchase Agreement of even date herewith, and each person purchasing shares of such stock pursuant to such Series E Preferred Stock Purchase Agreement shall be entitled to execute
counterparts of this Agreement and hold the rights conferred upon the Series E Holders herein, and such persons shall be treated as parties to this Agreement without any action or consent by any other party hereto; and 
  
 4.5.2 Continuation. This Agreement shall continue in
full force and effect with respect to the parties who have executed this Agreement, regardless of whether or not any of the persons identified in Section 4.5.1, above, hereafter executes a counterpart or this Agreement or otherwise are treated as
parties to this Agreement. 
  
 4.6 Successors and
Assigns. This Agreement shall be binding upon, and inure to the benefit of, the parties to this Agreement and their respective successors and assigns; provided that the registration rights conferred upon Investor in Section 2 of this
Agreement are personal to Investor and may not be assigned to any purchaser of all or any portion of the Shares. 
  
 4.7 Entire Agreement. This Agreement (i) represents the entire agreement of the parties regarding the subject matter hereof, and
supersedes all prior or contemporaneous understandings, whether oral or written, regarding such subject matter, and (ii) may not be modified or amended, except by a written instrument executed by the party against whom enforcement of any such
amendment may be sought. 
  
 4.8 Separability;
Severability. Unless expressly provided in this Agreement, the rights of each Holder under this Agreement are several rights, not rights jointly held with any other Holders. Any invalidity, illegality or limitation on the enforceability of
this Agreement with respect to any Holder shall not affect the validity, legality or enforceability of this Agreement with respect to the other Holders. If any provision of this Agreement is judicially determined to be invalid, illegal or
unenforceable, the validity, legality and enforceability of the remaining provisions shall not be affected or impaired. 
  

 -12- 

 4.9 Stock Splits. All references to numbers of shares in this Agreement shall be
appropriately adjusted to reflect any stock dividend, split, combination or other recapitalization of shares by the Company occurring after the date of this Agreement. 
  
 4.10 Effective Date. The effective date of this Agreement, as to each Investor hereunder, is the first date as
of which this Agreement has been signed by such Investor and the Company and the “Closing” described in the Purchase Agreement has occurred. 
  
 [Signatures appear on the following page.] 
  

 -13- 

 IN WITNESS WHEREOF, the parties have executed this Investor Rights Agreement on the day and year
first set forth above. 
  

					
	 	 	 	 	“COMPANY:”
			
	 	 	 	 	 CALLWAVE, INC., a California corporation

			
	  

	 	 By:
	 	     /s/    ROBERT A.
DOLAN        

	Date	 	 	 	 Robert A. Dolan, CEO and Secretary

		
	 	 	Address and Facsimile No. for Notices:
		
	 	 	 136 W. Canon Perdido, Ste. A

	 	 	 Santa Barbara, CA 93101

		
	 	 	 Facsimile: (805) 690-4202

  
 [Signatures
continued on following page.] 
  

 -14- 

 INVESTORS’ SIGNATURES: 
  

			
	  
 /s/ Nick Abood

	  	 Nick Abood

	Investor’s Signature	  	 Investor’s Signature
  
  
  

		
	 Abood’s Family Trust

	  	

	Investor’s Printed Name	  	 Investor’s Printed Name
  
  
  

		
	 Trustee

	  	

	Title of Person Signing (for Investors that are entities or trusts)	  	Title of Person Signing (for Investors that are entities or trusts)
		
	Address and Facsimile No. for Notices:	  	 
		
	 4254 Motor Avenue

	  	 
	 Culver City, CA 90232

	  	 
	  

	  	 
	 Facsimile No.: (213) 746-1542

	  	 

 INVESTORS’ SIGNATURES: 
  

			
	  
 /s/ FW Albershardt

	  	 /s/ Joan S. Albershardt

	Investor’s Signature	  	 Investor’s Signature
  
  
  

		
	 Fritz W. Albershardt

	  	

	Investor’s Printed Name	  	 Investor’s Printed Name
  
  
  

		
	 Trustee

	  	

	Title of Person Signing (for Investors that are entities or trusts)	  	Title of Person Signing (for Investors that are entities or trusts)
		
	Address and Facsimile No. for Notices:	  	 
		
	 4108 Via Largavista

	  	 
	 Palos Verdes Estates, CA 90274

	  	 
	  

	  	 
	 Facsimile No.: (530) 509-4822

	  	 

 INVESTORS’ SIGNATURES: 
  

			
	  
 /s/ Kurt E.
Albershardt

	  	 /s/ Julianna C. Flynn

	Investor’s Signature	  	 Investor’s Signature
  
  
  

		
	 Kurt E. Albershardt

	  	 Julianna C. Flynn

	Investor’s Printed Name	  	 Investor’s Printed Name
  
  
  

		
	  

	  	  

	Title of Person Signing (for Investors that are entities or trusts)	  	Title of Person Signing (for Investors that are entities or trusts)
		
	Address and Facsimile No. for Notices:	  	 
		
	 316 California Avenue, #149

	  	 
	 Reno, NV 89509

	  	 
	  

	  	 
	 Facsimile No.: (775) 993-9009

	  	 

  

 INVESTORS’ SIGNATURES: 
  

			
	  
  

	  	 /s/ Illegible

	Investor’s Signature	  	 Investor’s Signature
  
  
  

		
	  

	  	 Alda Limited Partnership

	Investor’s Printed Name	  	 Investor’s Printed Name
  
  
  

		
	  

	  	 President

	Title of Person Signing (for Investors that are entities or trusts)	  	Title of Person Signing (for Investors that are entities or trusts)
		
	Address and Facsimile No. for Notices:	  	 
		
	 1764 Litchfield Tpke. Ste. 203

	  	 
	 Woodbridge, CT 06525-2353

	  	 
	  

	  	 
	 Facsimile No.: (775) 418-5242

	  	 

 INVESTORS’ SIGNATURES: 
  

			
	  
 /s/ Illegible

	  	  

	Investor’s Signature	  	 Investor’s Signature
  
  
  

		
	 Applegreen Partners

	  	  

	Investor’s Printed Name	  	 Investor’s Printed Name
  
  
  

		
	 General Partner

	  	

	Title of Person Signing (for Investors that are entities or trusts)	  	Title of Person Signing (for Investors that are entities or trusts)
		
	Address and Facsimile No. for Notices:	  	 
		
	 Geo Capital LLC

	  	 
	 825 Third Ave, 32 Fl

	  	 
	 N.Y., N.Y. 10022

	  	 
	 Facsimile No.: (212) 486-4469

	  	 

 INVESTORS’ SIGNATURES: 
  

			
	  
 /s/ Scott C.
Brittingham

	  	

	Investor’s Signature	  	 Investor’s Signature
  
  
  

		
	 Scott C. Brittingham Living Trust

	  	

	Investor’s Printed Name	  	 Investor’s Printed Name
  
  
  

		
	 Director/officer

	  	

	Title of Person Signing (for Investors that are entities or trusts)	  	Title of Person Signing (for Investors that are entities or trusts)
		
	Address and Facsimile No. for Notices:	  	 
		
	 1559 East Valley Road

	  	 
	 Santa Barbara, CA 93108

	  	 
	  

	  	 
	 Facsimile No.: (805) 969-5441

	  	 

 INVESTORS’ SIGNATURES: 
  

			
	  
 /s/ Barry
Rubenstein

	  	

	Investor’s Signature	  	 Investor’s Signature
  
  
  

		
	 Brookwood Partners, L.P.

	  	

	Investor’s Printed Name	  	 Investor’s Printed Name
  
  
  

		
	 General Partner

	  	

	Title of Person Signing (for Investors that are entities or trusts)	  	Title of Person Signing (for Investors that are entities or trusts)
		
	Address and Facsimile No. for Notices:	  	 
		
	 68 Wheatley Road

	  	 
	 Brookville, N.Y. 11545

	  	 
	  

	  	 
	 Facsimile No.: (516) 626-3073

	  	 

 INVESTORS’ SIGNATURES: 
  

			
	  
 /s/ Robert V.
Daiello

	  	 /s/ Marie Ann Daiello

	Investor’s Signature	  	 Investor’s Signature
  
  
  

		
	 Robert V. Daiello

	  	 Marie Ann Daiello

	Investor’s Printed Name	  	 Investor’s Printed Name
  
  
  

		
	  

	  	  

	Title of Person Signing (for Investors that are entities or trusts)	  	Title of Person Signing (for Investors that are entities or trusts)
		
	Address and Facsimile No. for Notices:	  	 
		
	 146 East Colt Road

	  	 
	 Tempe, AX 85284

	  	 
	  

	  	 
	 Facsimile No.: (480) 345-6698

	  	 

 INVESTORS’ SIGNATURES: 
  

			
	  
 By:         /s/
Illegible

	  	  

	Investor’s Signature	  	 Investor’s Signature
  
  
  

		
	 DeAnza Properties, A California General Partnership

	  	  

	Investor’s Printed Name	  	 Investor’s Printed Name
  
  
  

		
	 General Partner

	  	

	Title of Person Signing (for Investors that are entities or trusts)	  	Title of Person Signing (for Investors that are entities or trusts)
		
	Address and Facsimile No. for Notices:	  	 
		
	 DeAnza Properties

	  	 
	 920 West Fremont Ave

	  	 
	 Sunnyvale, CA 94087

	  	 
	 Facsimile No.: (408) 738-0231

	  	 

 INVESTORS’ SIGNATURES: 
  

			
	  
 /s/ Barry
Fingerhut

	  	

	Investor’s Signature	  	 Investor’s Signature
  
  
  

		
	 Barry Fingerhut

	  	

	Investor’s Printed Name	  	 Investor’s Printed Name
  
  
  

		
	  

	  	  

	Title of Person Signing (for Investors that are entities or trusts)	  	Title of Person Signing (for Investors that are entities or trusts)
		
	Address and Facsimile No. for Notices:	  	 
		
	 GeoCapital LLC

	  	 
	 825 Third Avenue, 32 Fl

	  	 
	 N.Y., N.Y. 10022

	  	 
	 Facsimile No.: (212) 486-4469

	  	 

 INVESTORS’ SIGNATURES: 
  

			
	  
  

	  	 /s/ Michael D. Grable

	Investor’s Signature	  	 Investor’s Signature
  
  
  

		
	  

	  	 Michael D. Grable

	Investor’s Printed Name	  	 Investor’s Printed Name
  
  
  

		
	  

	  	  

	Title of Person Signing (for Investors that are entities or trusts)	  	Title of Person Signing (for Investors that are entities or trusts)
		
	Address and Facsimile No. for Notices:	  	 
		
	  

	  	 
	  

	  	 
	  

	  	 
	 Facsimile No.: 

	  	 

 INVESTORS’ SIGNATURES: 
  

			
	  
 /s/ G. Dale Gray

	  	

	Investor’s Signature	  	 Investor’s Signature
  
  
  

		
	 G. Dale Gray

	  	

	Investor’s Printed Name	  	 Investor’s Printed Name
  
  
  

		
	  

	  	  

	Title of Person Signing (for Investors that are entities or trusts)	  	Title of Person Signing (for Investors that are entities or trusts)
		
	Address and Facsimile No. for Notices:	  	 
		
	  

	  	 
	  

	  	 
	  

	  	 
	 Facsimile No.: 

	  	 

 INVESTORS’ SIGNATURES: 
  

			
	  
 /s/ Peter V.
Sperling

	  	  

	Investor’s Signature	  	 Investor’s Signature
  
  
  

		
	 Hermes Group

	  	

	Investor’s Printed Name	  	 Investor’s Printed Name
  
  
  

		
	 Peter V. Sperling—Principal

	  	

	Title of Person Signing (for Investors that are entities or trusts)	  	Title of Person Signing (for Investors that are entities or trusts)
		
	Address and Facsimile No. for Notices:	  	 
		
	  

	  	 
	  

	  	 
	  

	  	 
	 Facsimile No.: 

	  	 

 INVESTORS’ SIGNATURES: 
  

			
	  
 /s/ David S.
Isenberg

	  	 /s/ Paula Blumenthal

	Investor’s Signature	  	 Investor’s Signature
  
  
  

		
	 David S. Isenberg

	  	 Paula Blumenthal

	Investor’s Printed Name	  	 Investor’s Printed Name
  
  
  

		
	 Note: JTWROS

	  	

	Title of Person Signing (for Investors that are entities or trusts)	  	Title of Person Signing (for Investors that are entities or trusts)
		
	Address and Facsimile No. for Notices:	  	 
		
	 18 S. Wickom Dr.

	  	 
	 Westfield, NJ 07090

	  	 
	  

	  	 
	 Facsimile No.: (775) 414-4979

	  	 

 INVESTORS’ SIGNATURES: 
  

			
	  
  

	  	 /s/ Palmer G. Jackson, Jr.

	Investor’s Signature	  	 Investor’s Signature
  
  
  

		
	  

	  	 Palmer G. Jackson, Jr.

	Investor’s Printed Name	  	 Investor’s Printed Name
  
  
  

		
	  

	  	  

	Title of Person Signing (for Investors that are entities or trusts)	  	Title of Person Signing (for Investors that are entities or trusts)
		
	Address and Facsimile No. for Notices:	  	 
		
	  

	  	 
	  

	  	 
	  

	  	 
	 Facsimile No.:

	  	 

 INVESTORS’ SIGNATURES: 
  

			
	  
 /s/ Richard A. Kimball,
Jr.

	  	  

	Investor’s Signature	  	 Investor’s Signature
  
  
  

		
	 Richard A. Kimball, Jr.

	  	  

	Investor’s Printed Name	  	 Investor’s Printed Name
  
  
  

		
	  

	  	  

	Title of Person Signing (for Investors that are entities or trusts)	  	Title of Person Signing (for Investors that are entities or trusts)
		
	Address and Facsimile No. for Notices:	  	 
		
	 755 Park Ave.

	  	 
	 N.Y., N.Y. 10021

	  	 
	  

	  	 
	 Facsimile No.: (212) 759-8878

	  	 

 INVESTORS’ SIGNATURES: 
  

			
	  
 /s/ Michael A.
Kramer

	  	  

	Investor’s Signature	  	 Investor’s Signature
  
  
  

		
	 Michael A. Kramer

	  	

	Investor’s Printed Name	  	 Investor’s Printed Name
  
  
  

		
	  

	  	  

	Title of Person Signing (for Investors that are entities or trusts)	  	Title of Person Signing (for Investors that are entities or trusts)
		
	Address and Facsimile No. for Notices:	  	 
		
	 1247 Oenoke Ridge

	  	 
	 New Canaan, CT 06840

	  	 
	  

	  	 
	 Facsimile No.: (203) 972-7268

	  	 

 INVESTORS’ SIGNATURES: 
  

			
	  
 /s/ Irwin Lieber

	  	  

	Investor’s Signature	  	 Investor’s Signature
  
  
  

		
	 Irwin Lieber

	  	  

	Investor’s Printed Name	  	 Investor’s Printed Name
  
  
  

		
	  

	  	  

	Title of Person Signing (for Investors that are entities or trusts)	  	Title of Person Signing (for Investors that are entities or trusts)
		
	Address and Facsimile No. for Notices:	  	 
		
	 GeoCapital LLC

	  	 
	 825 Third Avenue, 32 Fl

	  	 
	 N.Y., N.Y. 10022

	  	 
	 Facsimile No.: (212) 486-4469

	  	 

 INVESTORS’ SIGNATURES: 
  

			
	  
 /s/ Alan C. Maltz

	  	  

	Investor’s Signature	  	 Investor’s Signature
  
  
  

		
	 Alan C. Maltz

	  	  

	Investor’s Printed Name	  	 Investor’s Printed Name
  
  
  

		
	  

	  	  

	Title of Person Signing (for Investors that are entities or trusts)	  	Title of Person Signing (for Investors that are entities or trusts)
		
	Address and Facsimile No. for Notices:	  	 
		
	  

	  	 
	  

	  	 
	  

	  	 
	 Facsimile No.:

	  	 

 INVESTORS’ SIGNATURES: 
  

			
	  
 /s/ Illegible

	  	  

	Investor’s Signature	  	 Investor’s Signature
  
  
  

		
	 Maltz Associates LP

	  	  

	Investor’s Printed Name	  	 Investor’s Printed Name
  
  
  

		
	 General Partner

	  	  

	Title of Person Signing (for Investors that are entities or trusts)	  	Title of Person Signing (for Investors that are entities or trusts)
		
	Address and Facsimile No. for Notices:	  	 
		
	  

	  	 
	  

	  	 
	  

	  	 
	 Facsimile No.:

	  	 

 INVESTORS’ SIGNATURES: 
  

			
	  
 /s/ John D. Markel

	  	  

	Investor’s Signature	  	 Investor’s Signature
  
  
  

		
	 John D. Markel

	  	  

	Investor’s Printed Name	  	 Investor’s Printed Name
  
  
  

		
	  

	  	  

	Title of Person Signing (for Investors that are entities or trusts)	  	Title of Person Signing (for Investors that are entities or trusts)
		
	Address and Facsimile No. for Notices:	  	 
		
	 3214 Campanil Dr

	  	 
	 Santa Barbara, CA 93019

	  	 
	  

	  	 
	 Facsimile No.: (805) 687-9745

	  	 

 INVESTORS’ SIGNATURES: 
  

			
	  
  

	  	 /s/ Patrick McBrien

	Investor’s Signature	  	 Investor’s Signature
  
  
  

		
	  

	  	 Patrick McBrien

	Investor’s Printed Name	  	 Investor’s Printed Name
  
  
  

		
	  

	  	  

	Title of Person Signing (for Investors that are entities or trusts)	  	Title of Person Signing (for Investors that are entities or trusts)
		
	Address and Facsimile No. for Notices:	  	 
		
	  

	  	 
	  

	  	 
	  

	  	 
	 Facsimile No.:

	  	 

 INVESTORS’ SIGNATURES: 
  

			
	  
 /s/ David
McClintock

	  	  

	Investor’s Signature	  	 Investor’s Signature
  
  
  

		
	 David McClintock

	  	  

	Investor’s Printed Name	  	 Investor’s Printed Name
  
  
  

		
	  

	  	  

	Title of Person Signing (for Investors that are entities or trusts)	  	Title of Person Signing (for Investors that are entities or trusts)
		
	Address and Facsimile No. for Notices:	  	 
		
	  

	  	 
	  

	  	 
	  

	  	 
	 Facsimile No.:

	  	 

 INVESTORS’ SIGNATURES: 
  

			
	  
 /s/ James T. McClintock,
Jr.

	  	  

	Investor’s Signature	  	 Investor’s Signature
  
  
  

		
	 James Thomas McClintock, Jr.

	  	  

	Investor’s Printed Name	  	 Investor’s Printed Name
  
  
  

		
	  

	  	  

	Title of Person Signing (for Investors that are entities or trusts)	  	Title of Person Signing (for Investors that are entities or trusts)
		
	Address and Facsimile No. for Notices:	  	 
		
	 P.O. Box 931194

	  	 
	 Los Angeles, CA 90093

	  	 
	  

	  	 
	 Facsimile No.: (209) 882-7723

	  	 

 INVESTORS’ SIGNATURES: 
  

			
	  
 /s/ Joetta
McClintock

	  	  

	Investor’s Signature	  	 Investor’s Signature
  
  
  

		
	 Joetta McClintock

	  	  

	Investor’s Printed Name	  	 Investor’s Printed Name
  
  
  

		
	  

	  	  

	Title of Person Signing (for Investors that are entities or trusts)	  	Title of Person Signing (for Investors that are entities or trusts)
		
	Address and Facsimile No. for Notices:	  	 
		
	  

	  	 
	  

	  	 
	  

	  	 
	 Facsimile No.: (805) 969-6778

	  	 

 INVESTORS’ SIGNATURES: 
  

			
	  
 /s/ Tom Murphy

	  	  

	Investor’s Signature	  	 Investor’s Signature
  
  
  

		
	 Thomas Michael Murphy

	  	  

	Investor’s Printed Name	  	 Investor’s Printed Name
  
  
  

		
	  

	  	  

	Title of Person Signing (for Investors that are entities or trusts)	  	Title of Person Signing (for Investors that are entities or trusts)
		
	Address and Facsimile No. for Notices:	  	 
		
	 2038 Chino St.

	  	 
	 Santa Barbara, CA 93101

	  	 
	  

	  	 
	 Facsimile No.:

	  	 

 INVESTORS’ SIGNATURES: 
  

			
	  
  

	  	 /s/ Robert Senoff

	Investor’s Signature	  	 Investor’s Signature
  
  
  

		
	  

	  	 Robert Senoff

	Investor’s Printed Name	  	 Investor’s Printed Name
  
  
  

		
	  

	  	 Managing Member

	Title of Person Signing (for Investors that are entities or trusts)	  	Title of Person Signing (for Investors that are entities or trusts) New Millennium Venture Partners II, LLC G.P. for New Millennium Partners II (non-Q) L.P.
		
	Address and Facsimile No. for Notices:	  	Address and Facsimile No. for Notices:
		
	  

	  	 2001 Union Street, Suite 690

	  

	  	 San Francisco, CA 94123

	  

	  	  

	 Facsimile No.:

	  	 Facsimile No.:

 INVESTORS’ SIGNATURES: 
  

			
	  
  

	  	 /s/ Robert Senoff

	Investor’s Signature	  	 Investor’s Signature
  
  
  

		
	  

	  	 Robert Senoff

	Investor’s Printed Name	  	 Investor’s Printed Name
  
  
  

		
	  

	  	 Managing Member

	Title of Person Signing (for Investors that are entities or trusts)	  	Title of Person Signing (for Investors that are entities or trusts) New Millennium Venture Partners II, LLC G.P. for New Millennium Partners-CallWave, L.P.
		
	Address and Facsimile No. for Notices:	  	 
		
	 2001 Union Street, Suite 690

	  	 
	 San Francisco, CA 94123

	  	 
	  

	  	 
	 Facsimile No.: (415) 749-2823

	  	 

 INVESTORS’ SIGNATURES: 
  

			
	  
  

	  	 /s/ Robert Senoff

	Investor’s Signature	  	 Investor’s Signature
  
  
  

		
	  

	  	 Robert Senoff

	Investor’s Printed Name	  	 Investor’s Printed Name
  
  
  

		
	  

	  	 Managing Member

	Title of Person Signing (for Investors that are entities or trusts)	  	Title of Person Signing (for Investors that are entities or trusts) New Millennium Venture Partners II, LLC G.P. for New Millennium Partners II (non-Q), L.P.
		
	Address and Facsimile No. for Notices:	  	 
		
	 2001 Union Street, Suite 690

	  	 
	 San Francisco, CA 94123

	  	 
	  

	  	 
	 Facsimile No.: (415) 749-2823

	  	 

 INVESTORS’ SIGNATURES: 
  

			
	  
  

	  	 /s/ Robert Senoff

	Investor’s Signature	  	 Investor’s Signature
  
  
  

		
	  

	  	 Robert Senoff

	Investor’s Printed Name	  	 Investor’s Printed Name
  
  
  

		
	  

	  	 Managing Member

	Title of Person Signing (for Investors that are entities or trusts)	  	Title of Person Signing (for Investors that are entities or trusts) New Millennium Venture Partners II, LLC G.P. for New Millennium Partners II (non-Q), L.P.
		
	Address and Facsimile No. for Notices:	  	 
		
	 2001 Union Street, Suite 690

	  	 
	 San Francisco, CA 94123

	  	 
	  

	  	 
	 Facsimile No.: (415) 749-2823

	  	 

 INVESTORS’ SIGNATURES: 
  

			
	  
 /s/ Victor
Oristano

	  	  

	Investor’s Signature	  	 Investor’s Signature
  
  
  

		
	 Victor Oristano

	  	  

	Investor’s Printed Name	  	 Investor’s Printed Name
  
  
  

		
	  

	  	  

	Title of Person Signing (for Investors that are entities or trusts)	  	Title of Person Signing (for Investors that are entities or trusts)
		
	Address and Facsimile No. for Notices:	  	 
		
	 1764 Litchfield Tpke. Ste. 203

	  	 
	 Woodbridge, CT 06525-2353

	  	 
	  

	  	 
	 Facsimile No.: (775) 418-5242

	  	 

 INVESTORS’ SIGNATURES: 
  

			
	  
 /s/ Victor
Oristano

	  	  

	Investor’s Signature	  	 Investor’s Signature
  
  
  

		
	 Oristano Foundation

	  	  

	Investor’s Printed Name	  	 Investor’s Printed Name
  
  
  

		
	  

	  	  

	Title of Person Signing (for Investors that are entities or trusts)	  	Title of Person Signing (for Investors that are entities or trusts)
		
	Address and Facsimile No. for Notices:	  	 
		
	 1764 Litchfield Tpke. Ste. 203

	  	 
	 Woodbridge, CT 06525-2353

	  	 
	  

	  	 
	 Facsimile No.: (775) 418-5242

	  	 

 INVESTORS’ SIGNATURES: 
  

			
	  
 /s/ John Petote

	  	  

	Investor’s Signature	  	 Investor’s Signature
  
  
  

		
	 John Petote

	  	  

	Investor’s Printed Name	  	 Investor’s Printed Name
  
  
  

		
	  

	  	  

	Title of Person Signing (for Investors that are entities or trusts)	  	Title of Person Signing (for Investors that are entities or trusts)
		
	Address and Facsimile No. for Notices:	  	 
		
	  

	  	 
	  

	  	 
	  

	  	 
	 Facsimile No.:

	  	 

 INVESTORS’ SIGNATURES: 
  

			
	  
 /s/ Barry
Rubenstein

	  	  

	Investor’s Signature	  	 Investor’s Signature
  
  
  

		
	 Barry Rubenstein

	  	  

	Investor’s Printed Name	  	 Investor’s Printed Name
  
  
  

		
	  

	  	  

	Title of Person Signing (for Investors that are entities or trusts)	  	Title of Person Signing (for Investors that are entities or trusts)
		
	Address and Facsimile No. for Notices:	  	 
		
	 68 Wheatley Road

	  	 
	 Brookville, N.Y. 11545

	  	 
	  

	  	 
	 Facsimile No.: (516) 626-3073

	  	 

 INVESTORS’ SIGNATURES: 
  

			
	  
 /s/ Cliff R.
Scholle

	  	 /s/ Diane M. Scholle

	Investor’s Signature	  	 Investor’s Signature
  
  
  

		
	 Scholle Family Trust Dated 11-19-96

	  	 Scholle Family Trust Dated 11-19-96

	Investor’s Printed Name	  	 Investor’s Printed Name
  
  
  

		
	 Trustee

	  	 Trustee

	Title of Person Signing (for Investors that are entities or trusts)	  	Title of Person Signing (for Investors that are entities or trusts)
		
	Address and Facsimile No. for Notices:	  	 
		
	 101 Sherwood Dr.

	  	 
	 Santa Barbara, CA 93110

	  	 
	  

	  	 
	 Facsimile No.: (805) 967-4181

	  	 

 INVESTORS’ SIGNATURES: 
  

			
	  
 /s/ Charles F.
Schwartz

	  	 /s/ Christine Schwartz

	Investor’s Signature	  	 Investor’s Signature
  
  
  

		
	 Charles F. Schwartz

	  	 Christine Schwartz

	Investor’s Printed Name	  	 Investor’s Printed Name
  
  
  

		
	  

	  	  

	Title of Person Signing (for Investors that are entities or trusts)	  	Title of Person Signing (for Investors that are entities or trusts)
		
	Address and Facsimile No. for Notices:	  	 
		
	  

	  	 
	  

	  	 
	  

	  	 
	 Facsimile No.:

	  	 

 INVESTORS’ SIGNATURES: 
  

			
	  
 /s/ Terry L. Scott

	  	  

	Investor’s Signature	  	 Investor’s Signature
  
  
  

		
	 Terry L. Scott

	  	  

	Investor’s Printed Name	  	 Investor’s Printed Name
  
  
  

		
	  

	  	  

	Title of Person Signing (for Investors that are entities or trusts)	  	Title of Person Signing (for Investors that are entities or trusts)
		
	Address and Facsimile No. for Notices:	  	 
		
	 1704 Riviera Dr.

	  	 
	 Plano, TX 75093

	  	 
	  

	  	 
	 Facsimile No.: (972) 713-6526

	  	 

 INVESTORS’ SIGNATURES: 
  

			
	  
 /s/ Barry
Rubenstein

	  	  

	Investor’s Signature	  	 Investor’s Signature
  
  
  

		
	 Seneca Ventures

	  	  

	Investor’s Printed Name	  	 Investor’s Printed Name
  
  
  

		
	 General Partner

	  	  

	Title of Person Signing (for Investors that are entities or trusts)	  	Title of Person Signing (for Investors that are entities or trusts)
		
	Address and Facsimile No. for Notices:	  	 
		
	 68 Wheatley Road

	  	 
	 Brookville, N.Y. 11545

	  	 
	  

	  	 
	 Facsimile No.: (516) 626-3073

	  	 

 INVESTORS’ SIGNATURES: 
  

			
	  
 /s/ Douglas Smith

	  	  

	Investor’s Signature	  	 Investor’s Signature
  
  
  

		
	 Douglas Smith

	  	  

	Investor’s Printed Name	  	 Investor’s Printed Name
  
  
  

		
	  

	  	  

	Title of Person Signing (for Investors that are entities or trusts)	  	Title of Person Signing (for Investors that are entities or trusts)
		
	Address and Facsimile No. for Notices:	  	 
		
	 161 East 91st St. Apt. 40

	  	 
	 New York, N.Y. 10128

	  	 
	  

	  	 
	 Facsimile No.: (209) 885-9559

	  	 

 INVESTORS’ SIGNATURES: 
  

			
	  
 /s/ Bradley I.
Sobell

	  	 /s/ Howard A .Sobell

	Investor’s Signature	  	 Investor’s Signature
  
  
  

		
	 Bradley I. Sobell

	  	 Howard A. Sobell

	Investor’s Printed Name	  	 Investor’s Printed Name
  
  
  

		
	  

	  	  

	Title of Person Signing (for Investors that are entities or trusts)	  	Title of Person Signing (for Investors that are entities or trusts)
		
	Address and Facsimile No. for Notices:	  	 
		
	 10051 Jamestown St.

	  	 
	 Ventura, CA 93004

	  	 
	  

	  	 
	 Facsimile No.: (805) 690-9312

 (818) 891-3121

	  	 

 INVESTORS’ SIGNATURES: 
  

			
	  
 /s/ Peter V.
Sperling

	  	  

	Investor’s Signature	  	 Investor’s Signature
  
  
  

		
	 John G. Sperling 1994 Irrevocable Trust

	  	  

	Investor’s Printed Name	  	 Investor’s Printed Name
  
  
  

		
	 Peter V. Sperling—Trustee

	  	  

	Title of Person Signing (for Investors that are entities or trusts)	  	Title of Person Signing (for Investors that are entities or trusts)
		
	Address and Facsimile No. for Notices:	  	 
		
	  

	  	 
	  

	  	 
	  

	  	 
	 Facsimile No.:

	  	 

 INVESTORS’ SIGNATURES: 
  

			
	  
 /s/ Peter V.
Sperling

	  	  

	Investor’s Signature	  	 Investor’s Signature
  
  
  

		
	 Peter V. Sperling

	  	  

	Investor’s Printed Name	  	 Investor’s Printed Name
  
  
  

		
	  

	  	  

	Title of Person Signing (for Investors that are entities or trusts)	  	Title of Person Signing (for Investors that are entities or trusts)
		
	Address and Facsimile No. for Notices:	  	 
		
	  

	  	 
	  

	  	 
	  

	  	 
	 Facsimile No.:

	  	 

 INVESTORS’ SIGNATURES: 
  

			
	  
 /s/ Illegible

	  	  

	Investor’s Signature	  	 Investor’s Signature
  
  
  

		
	 V.G. Investments, A California limited partnership

	  	  

	Investor’s Printed Name	  	 Investor’s Printed Name
  
  
  

		
	 General Partner

	  	  

	Title of Person Signing (for Investors that are entities or trusts)	  	Title of Person Signing (for Investors that are entities or trusts)
		
	Address and Facsimile No. for Notices:	  	 
		
	 DeAnza Properties

	  	 
	 920 West Fremont Avenue

	  	 
	 Sunnyvale, CA 94087

	  	 
	 Facsimile No.: (408) 738-0231

	  	 

 INVESTORS’ SIGNATURES: 
  

			
	  
 /s/ Albert Vitale

	  	  

	Investor’s Signature	  	 Investor’s Signature
  
  
  

		
	 Albert Vitale

	  	  

	Investor’s Printed Name	  	 Investor’s Printed Name
  
  
  

		
	  

	  	  

	Title of Person Signing (for Investors that are entities or trusts)	  	Title of Person Signing (for Investors that are entities or trusts)
		
	Address and Facsimile No. for Notices:	  	 
		
	  

	  	 
	  

	  	 
	  

	  	 
	 Facsimile No.:

	  	 

 INVESTORS’ SIGNATURES: 
  

			
	  
 /s/ Barry
Rubenstein

	  	  

	Investor’s Signature	  	 Investor’s Signature
  
  
  

		
	 Wheatley Associates III, L.P.

	  	  

	Investor’s Printed Name	  	 Investor’s Printed Name
  
  
  

		
	 CEO of General Partner

	  	  

	Title of Person Signing (for Investors that are entities or trusts)	  	Title of Person Signing (for Investors that are entities or trusts)
		
	Address and Facsimile No. for Notices:	  	 
		
	 80 Cutterhill Road

	  	 
	 Suite 311

	  	 
	 Great Neck, N.Y. 11201

	  	 
	 Facsimile No.: (516) 773-0996

	  	 

 INVESTORS’ SIGNATURES: 
  

			
	  
 /s/ Barry
Rubenstein

	  	  

	Investor’s Signature	  	 Investor’s Signature
  
  
  

		
	 Wheatley Foreign Partners, L.P.

	  	  

	Investor’s Printed Name	  	 Investor’s Printed Name
  
  
  

		
	 CEO of General Partner

	  	  

	Title of Person Signing (for Investors that are entities or trusts)	  	Title of Person Signing (for Investors that are entities or trusts)
		
	Address and Facsimile No. for Notices:	  	 
		
	 80 Cutterhill Road

	  	 
	 Suite 311

	  	 
	 Great Neck, N.Y. 11201

	  	 
	 Facsimile No.: (516) 773-0996

	  	 

 INVESTORS’ SIGNATURES: 
  

			
	  
 /s/ Barry
Rubenstein

	  	  

	Investor’s Signature	  	 Investor’s Signature
  
  
  

		
	 Wheatley Foreign Partners III, L.P.

	  	  

	Investor’s Printed Name	  	 Investor’s Printed Name
  
  
  

		
	 CEO of General Partner

	  	  

	Title of Person Signing (for Investors that are entities or trusts)	  	Title of Person Signing (for Investors that are entities or trusts)
		
	Address and Facsimile No. for Notices:	  	 
		
	 80 Cutterhill Road

	  	 
	 Suite 311

	  	 
	 Great Neck, N.Y. 11201

	  	 
	 Facsimile No.: (516) 773-0996

	  	 

 INVESTORS’ SIGNATURES: 
  

			
	  
 /s/ Barry
Rubenstein

	  	  

	Investor’s Signature	  	 Investor’s Signature
  
  
  

		
	 Wheatley Partners, L.P.

	  	  

	Investor’s Printed Name	  	 Investor’s Printed Name
  
  
  

		
	 CEO of General Partner

	  	  

	Title of Person Signing (for Investors that are entities or trusts)	  	Title of Person Signing (for Investors that are entities or trusts)
		
	Address and Facsimile No. for Notices:	  	 
		
	 80 Cutterhill Road

	  	 
	 Suite 311

	  	 
	 Great Neck, N.Y. 11201

	  	 
	 Facsimile No.: (516) 773-0996

	  	 

 INVESTORS’ SIGNATURES: 
  

			
	  
 /s/ Barry
Rubenstein

	  	  

	Investor’s Signature	  	 Investor’s Signature
  
  
  

		
	 Wheatley Partners II, L.P.

	  	  

	Investor’s Printed Name	  	 Investor’s Printed Name
  
  
  

		
	 General Partner

	  	  

	Title of Person Signing (for Investors that are entities or trusts)	  	Title of Person Signing (for Investors that are entities or trusts)
		
	Address and Facsimile No. for Notices:	  	 
		
	 80 Cutterhill Road

	  	 
	 Suite 311

	  	 
	 Great Neck, N.Y. 11201

	  	 
	 Facsimile No.: (516) 773-0996

	  	 

 INVESTORS’ SIGNATURES: 
  

			
	  
 /s/ Barry
Rubenstein

	  	  

	Investor’s Signature	  	 Investor’s Signature
  
  
  

		
	 Wheatley Partners III, L.P.

	  	  

	Investor’s Printed Name	  	 Investor’s Printed Name
  
  
  

		
	 CEO of General Partner

	  	  

	Title of Person Signing (for Investors that are entities or trusts)	  	Title of Person Signing (for Investors that are entities or trusts)
		
	Address and Facsimile No. for Notices:	  	 
		
	 80 Cutterhill Road

	  	 
	 Suite 311

	  	 
	 Great Neck, N.Y. 11201

	  	 
	 Facsimile No.: (516) 773-0996

	  	 

 INVESTORS’ SIGNATURES: 
  

			
	  
 /s/ Albert
Weisinger

	  	  

	Investor’s Signature	  	 Investor’s Signature
  
  
  

		
	 Albert Weisinger

	  	  

	Investor’s Printed Name	  	 Investor’s Printed Name
  
  
  

		
	  

	  	  

	Title of Person Signing (for Investors that are entities or trusts)	  	Title of Person Signing (for Investors that are entities or trusts)
		
	Address and Facsimile No. for Notices:	  	 
		
	  

	  	 
	  

	  	 
	  

	  	 
	 Facsimile No.:

	  	 

 INVESTORS’ SIGNATURES: 
  

			
	  
 /s/ Michael P. Whelan,
Jr.

	  	 /s/ Josephine Whalen

	Investor’s Signature	  	 Investor’s Signature
  
  
  

		
	 Michael P. Whelan, Jr.

	  	 Josephine Whalen

	Investor’s Printed Name	  	 Investor’s Printed Name
  
  
  

		
	  

	  	  

	Title of Person Signing (for Investors that are entities or trusts)	  	Title of Person Signing (for Investors that are entities or trusts)
		
	Address and Facsimile No. for Notices:	  	 
		
	  

	  	 
	  

	  	 
	  

	  	 
	 Facsimile No.:

	  	 

 INVESTORS’ SIGNATURES: 
  

			
	  
 /s/ Andrew
Winchester

	  	  

	Investor’s Signature	  	 Investor’s Signature
  
  
  

		
	 Andrew Winchester

	  	  

	Investor’s Printed Name	  	 Investor’s Printed Name
  
  
  

		
	  

	  	  

	Title of Person Signing (for Investors that are entities or trusts)	  	Title of Person Signing (for Investors that are entities or trusts)
		
	Address and Facsimile No. for Notices:	  	 
		
	 2825 Ben Lomond Dr.

	  	 
	 Santa Barbara, CA 93105

	  	 
	  

	  	 
	 Facsimile No.: (805) 898-0870

	  	 

 INVESTORS’ SIGNATURES: 
  

			
	  
 /s/ Barry
Rubenstein

	  	  

	Investor’s Signature	  	 Investor’s Signature
  
  
  

		
	 Woodland Partners

	  	  

	Investor’s Printed Name	  	 Investor’s Printed Name
  
  
  

		
	 General Partner

	  	  

	Title of Person Signing (for Investors that are entities or trusts)	  	Title of Person Signing (for Investors that are entities or trusts)
		
	Address and Facsimile No. for Notices:	  	 
		
	 68 Wheatley Road

	  	 
	 Brookville, N.Y. 11545

	  	 
	  

	  	 
	 Facsimile No.: (516) 626-3073

	  	 

 INVESTORS’ SIGNATURES: 
  

			
	  
 /s/ Barry
Rubenstein

	  	  

	Investor’s Signature	  	 Investor’s Signature
  
  
  

		
	 Woodland Venture Fund

	  	  

	Investor’s Printed Name	  	 Investor’s Printed Name
  
  
  

		
	 General Partner

	  	  

	Title of Person Signing (for Investors that are entities or trusts)	  	Title of Person Signing (for Investors that are entities or trusts)
		
	Address and Facsimile No. for Notices:	  	 
		
	 68 Wheatley Road

	  	 
	 Brookville, N.Y. 11545

	  	 
	  

	  	 
	 Facsimile No.: (516) 626-3073

	  	 

 INVESTORS’ SIGNATURES: 
  

			
	  
 /s/ Richard Ying

	  	  

	Investor’s Signature	  	 Investor’s Signature
  
  
  

		
	 Richard Ying

	  	  

	Investor’s Printed Name	  	 Investor’s Printed Name
  
  
  

		
	  

	  	  

	Title of Person Signing (for Investors that are entities or trusts)	  	Title of Person Signing (for Investors that are entities or trusts)
		
	Address and Facsimile No. for Notices:	  	 
		
	 2207 Fairview Ave. E147

	  	 
	 Seattle, WA 98102

	  	 
	  

	  	 
	 Facsimile No.: (206) 374-2149

	  	 

 INVESTORS’ SIGNATURES: 
  

			
	  
 /s/ Charles Ying

	  	  

	Investor’s Signature	  	 Investor’s Signature
  
  
  

		
	 Charles Ying

	  	  

	Investor’s Printed Name	  	 Investor’s Printed Name
  
  
  

		
	  

	  	 la12

	Title of Person Signing (for Investors that are entities or trusts)	  	Title of Person Signing (for Investors that are entities or trusts)
		
	Address and Facsimile No. for Notices:	  	 
		
	 2207 Fairview Ave. E147

	  	 
	 Seattle, WA 98102

	  	 
	  

	  	 
	 Facsimile No.: (206) 374-2149

	  	 

 INVESTORS’ SIGNATURES: 
  

			
	  
 /s/ Julie Zelnick

	  	 /s/ Scott Zelnick

	Investor’s Signature	  	 Investor’s Signature
  
  
  

		
	 Julie Zelnick

	  	 Scott Zelnick

	Investor’s Printed Name	  	 Investor’s Printed Name
  
  
  

		
	  

	  	  

	Title of Person Signing (for Investors that are entities or trusts)	  	Title of Person Signing (for Investors that are entities or trusts)
		
	Address and Facsimile No. for Notices:	  	 
		
	  

	  	 
	  

	  	 
	  

	  	 
	 Facsimile No.:

	  	 

 SCHEDULE A 
  
 INVESTORS HOLDING SHARES OF SERIES A
PREFERRED STOCK 
  

			
	 Investor

	  	 No. of Shares of
 Series A Preferred
Stock

	 Kurt E. Albershardt & Julianna C. Flynn
	  	30,000
	 Fritz W. & Joan S. Albershardt, Trustees of the Fritz W. & Joan S. Albershardt Family Trust Dated June 11, 1991
	  	30,000
	 Palmer G. Jackson, Jr.
	  	150,002
	 Maureen C. Laughlin & James L. Laughlin
	  	30,000
	 David C. McClintock
	  	12,000
	 James Thomas McClintock
	  	45,000
	 Joetta McClintock
	  	6,000
	 David L. Oster or Nancy H. Oster
	  	30,000
	 Bradley I. Sobel and Howard A. Sobel
	  	15,000
	 Peter V. & Stephanie G. Sperling
	  	300,003
	 	  	 
	 TOTAL
	  	648,005

 SCHEDULE B 
  
 INVESTORS HOLDING SHARES OF SERIES B
PREFERRED STOCK 
  

			
	 Investor

	  	 No. of Shares of
 Series B Preferred
Stock

	 Palmer G. Jackson, Jr.
	  	89,051
	 Lauglin Investment Co. Ltd. Partnership
	  	33,722
	 Mausner Family Trust
	  	41,667
	 Thomas Michael Murphy
	  	8,333
	 Charles Ying
	  	54,168
	 Richard Ying
	  	54,168
	 Michael D. Grable
	  	33,333
	 John Petote
	  	83,333
	 Kurt E. Albershardt & Julianna C. Flynn
	  	8,766
	 Fritz W. & Joan S. Albershardt, Trustees of the Fritz W. & Joan S. Albershardt Family Trust Dated June 11, 1991
	  	583
	 Maureen C. Laughlin & James L. Laughlin
	  	1,157
	 David C. McClintock
	  	302
	 Joetta McClintock
	  	130
	 James Thomas McClintock
	  	1,472
	 David L. Oster or Nancy H. Oster
	  	1,338
	 Bradley I. Sobel and Howard A. Sobel
	  	537
	 Patrick K. McBrien
	  	41,667
	 Peter V. & Stephanie G. Sperling
	  	2,333,334
	 Scott & Julie Zeinick
	  	41,666
	 	  	 
	 TOTAL
	  	2,828,727

 SCHEDULE C 
  
 INVESTORS HOLDING SHARES OF SERIES C
PREFERRED STOCK 
  

			
	 Investor

	  	 No. of Shares of
 Series C Preferred
Stock

	 Alan C. Maltz
	  	   200,000
	 Maltz Associates, L.P.
	  	     50,000
	 Albert C. Weisinger
	  	     20,833
	 Woodland Partners
	  	     83,333
	 Monica Masuda
	  	     41,666
	 John G. Sperling 1994 Irrevocable Trust
	  	   833,334
	 	  	 
	 TOTAL
	  	1,229,166

 SCHEDULE D 
  
 INVESTORS HOLDING SHARES OF SERIES D
PREFERRED STOCK 
  

			
	 Investor

	  	 No. of Shares of
 Series D Preferred Stock

	 Alan C. Maltz
	  	200,000
	 Albert C. Weisinger
	  	10,417
	 Alberto A. Vitale
	  	40,240
	 Alda Limited Partnership
	  	34,203
	 Barry K. Fingerhut
	  	20,833
	 Barry Rubenstein
	  	83,333
	 Charles F. and Christine Schwartz
	  	10,059
	 David S. Isenberg & Paula Blumenthal
	  	21,306
	 Douglass Munro Smith
	  	57,600
	 Geretz Investments, LP
	  	6,250
	 Irwin Lieber
	  	20,833
	 Jean S. Oristano
	  	16,096
	 Matthew Oristano
	  	34,203
	 Michael A. Kramer
	  	20,287
	 Michael F. Whalen, Jr. & Dr. Josephine Whalen
	  	10,140
	 The Oristano Foundation
	  	20,120
	 Abood Family Trust
	  	4,167
	 Patrick McBrien
	  	12,000
	 Peter Lynch and Susan McMullen Lynch
	  	10,059
	 R. Michael Crill
	  	62,500
	 Richard A. Kimball, Jr.
	  	20,833
	 Scott & Julie Zelnick
	  	10,000
	 Scott C. Brittingham, Living Trust
	  	20,833
	 Seneca Ventures, LP
	  	41,667
	 Sunil S. Kripalani
	  	9,658
	 Terry L. Scott
	  	10,059
	 Todd A. & Nancy J. Rowley
	  	12,072
	 Victor Oristano
	  	10,059
	 Woodland Partners
	  	41,667
	 Davis-Marrin Communications, Inc.
	  	21,784
	 G. Dale Gray as nominee (G. Dale Gray & Associates, LTD)
	  	4,167
	 G. Dale Gray as nominee (Warren Newall Bloss III)
	  	2,000
	 G. Dale Gray & Mary Hyder Gray
	  	4,167
	 The William & Sandra Kaszeta Trust
	  	5,208
	 Robert V. & Maria A. Daiello
	  	5,208
	 Michael D. Grable
	  	20,834
	 Community Associates Services
	  	41,667
	 New Millennium Partners—CallWave, LP
	  	625,000
	 Mausner Family 1997 Trust
	  	20,834
	 Woodland Venture Fund, LP
	  	83,333
		
	 TOTAL
	  	1,705,696

 SCHEDULE E 
  
 INVESTORS HOLDING SHARES OF SERIES E
PREFERRED STOCK 
  

										
	 Investor

	 	Original
Investment

	    	Accrued
Interest at
May 31, 2001

	    	Per Diem Interest
Accrual After
May 31, 2001

	 Hermes Group
	 	$	5,000,000.00	    	$	191,527.78	    	$	972.22
	 Peter V. Sperling
	 	 	3,300,000.00	    	 	100,352.78	    	 	641.67
	 John G. Sperling 1994 Irrevocable Trust
	 	 	1,000,000.00	    	 	51,527.78	    	 	194.44
	 Applegreen Partners
	 	 	50,000.00	    	 	3,140.28	    	 	9.72
	 Barry Fingerhut
	 	 	150,000.00	    	 	9,420.83	    	 	29.17
	 Brookwood Partners
	 	 	100,000.00	    	 	6,280.56	    	 	19.44
	 Irwin Lieber
	 	 	150,000.00	    	 	9,391.67	    	 	29.17
	 Seneca Ventures
	 	 	299,999.00	    	 	13,163.88	    	 	58.33
	 Woodland Partners
	 	 	150,000.00	    	 	9,420.83	    	 	29.17
	 Woodland Venture Fund
	 	 	299,999.00	    	 	13,163.88	    	 	58.33
	 Wheatley Partners
	 	 	498,187.43	    	 	18,414.07	    	 	96.87
	 Wheatley Partners II
	 	 	260,035.34	    	 	9,611.47	    	 	50.56
	 Wheatley Partners III
	 	 	1,744,643.80	    	 	64,485.69	    	 	339.24
	 Wheatley Foreign Partners
	 	 	42,208.25	    	 	1,560.10	    	 	8.21
	 Wheatley Foreign Partners III
	 	 	373,134.48	    	 	13,791.85	    	 	72.55
	 Wheatley Associates III
	 	 	381,792.93	    	 	14,111.83	    	 	74.24
	 New Millennium Partners II
	 	 	1,739,161.35	    	 	131,007.16	    	 	338.17
	 New Millennium Partners II Non-Q
	 	 	760,838.65	    	 	57,312.28	    	 	147.94
	 Scott C. Brittingharn, Living Trust
	 	 	100,000.00	    	 	3,966.67	    	 	19.44
	 Thomas Michael Murphy
	 	 	100,000.00	    	 	260.56	    	 	1.94
	 Douglass Monroe Smith
	 	 	20,054.00	    	 	187.17	    	 	3.90
	 Alberto Vitale
	 	 	27,100.00	    	 	152.81	    	 	5.27
	 Alda Limited Partnership
	 	 	24,999.75	    	 	82.64	    	 	4.86
	 Oristano Foundation
	 	 	15,002.56	    	 	49.59	    	 	2.92
	 Victor Oristano
	 	 	9,999.90	    	 	25.28	    	 	1.94
	 	 	 	 	    	 	 	    	 	 
	 TOTAL
	 	$	16,507,156.44	    	$	722,409.43	    	$	3,209.72

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00066-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00066-of-00352.parquet"}]]